Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3012413	p-gluk120	mmol/l (mmol/l)	1154	1667	0.00%
3012413	p-gluk-a2	mmol/l (mmol/l)	1100	1353	0.00%
3012413	2hgluk	mmol/l (mmol/l)	1086	1458	0.00%
3012413	120mgluk	MMOL/L (mmol/l)	471	734	0.00%
3012413	120mgluk	mmol/l (mmol/l)	352	573	0.00%
3012413	p-gluk-a2	— (—)	212	260	100.00%	Distribution not available
3012413	pt-gluk-r6:p-gluk2hnäyte	mmol/l (mmol/l)	145	194	0.00%
3012413	p-gluk-a2	mmol/l____ (mmol/l)	111	128	0.00%
3012413	120mp-glu	mmol/l (mmol/l)	93	95	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Insulin, fast-acting

636

1184

5.52

323.01

1.3

1.4

12.57

7.52

mmol/l

81.93

558

1156

Type 2 diabetes, wide definition

944

1299

4.65

307.65

1.2

1.3

11.81

7.30

mmol/l

104.73

838

1286

Diabetes, insulin treatment (Kela reimbursement)

1253

2027

3.73

307.65

1.3

1.4

11.77

7.01

mmol/l

154.23

1098

2013

Insulin, intermediate and long-acting

1004

1685

5.91

307.65

1.3

12.80

7.70

mmol/l

125.38

864

1646

Insulin, combination of fast acting with intermediate-acting or long-acting

1077

1887

5.30

307.65

1.3

12.56

7.62

mmol/l

127.66

932

1844

Insulin medication

1077

1538

5.96

307.65

1.3

1.4

12.56

6.91

mmol/l

159.05

932

1528

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1213

1760

4.15

307.65

1.3

1.4

11.77

6.69

mmol/l

165.29

1064

1749

Type 2 diabetes

1247

2164

3.38

284.18

1.3

1.4

10.99

6.59

mmol/l

144.97

1121

2154

Insulin, fast-acting or short human

639

1342

4.89

282.66

1.3

12.57

8.14

mmol/l

64.16

561

1286

Other (not insulin) diabetes medications

1226

2153

3.39

281.56

1.3

1.4

11.23

6.81

mmol/l

142.91

1090

2141

Diabetes medication

1361

2548

3.16

280.77

1.3

1.4

11.23

6.69

mmol/l

164.42

1219

2535

Dipeptidyl peptidase 4 (DPP-4) inhibitors

658

1043

5.03

278.50

1.2

12.45

7.90

mmol/l

73.27

556

1026

Diabetes mellitus

1321

2407

3.21

278.26

1.3

1.4

10.96

6.56

mmol/l

151.32

1198

2396

Diabetes, varying definitions

1302

2403

3.18

270.86

1.3

1.4

10.95

6.59

mmol/l

146.57

1181

2390

Type 2 diabetes, definitions combined, including avohilmo

1121

1988

3.30

246.72

1.3

1.4

10.70

6.65

mmol/l

120.52

1007

1978

Type 2 diabetes, definitions combined

1106

1963

3.32

246.00

1.3

1.4

10.80

6.65

mmol/l

123.07

990

1953

Biguanides

1157

2232

3.17

242.66

1.3

1.4

11.21

7.19

mmol/l

116.03

1020

2212

Type 2 diabetes, strict (exclude DM1)

1109

2007

3.25

239.50

1.3

1.4

10.79

6.73

mmol/l

118.61

992

1996

Glucagon-like peptide-1 (GLP-1) analogues

446

795

5.74

237.64

1.3

12.16

7.61

mmol/l

56.38

383

780

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

446

795

5.74

237.64

1.3

12.16

7.61

mmol/l

56.38

383

780

Diabetes mellitus in pregnancy

674

1190

3.70

178.91

1.7

1.4

7.50

7.07

mmol/l

2.63

659

1169

Type 1 diabetes

335

754

4.52

135.98

1.4

1.5

12.32

6.56

mmol/l

50.84

311

747

Combinations of oral blood glucose lowering drugs

298

611

4.96

135.74

1.2

12.43

7.92

mmol/l

28.51

238

597

Postpartum care and examination

243

218

7.20

130.05

1.5

1.3

6.32

9.64

mmol/l

20.47

243

212

Elevated blood glucose level

177

250

7.38

119.33

1.3

1.4

11.83

8.86

mmol/l

7.53

167

239

Other maternal disorders predominantly related to pregnancy

718

1702

2.68

113.91

1.6

1.3

7.48

7.57

mmol/l

0.28

703

1644

Sulfonylureas

291

508

4.61

112.72

1.2

12.81

7.99

mmol/l

44.20

241

500

Chronic pancreatitis

195

342

5.87

106.21

1.4

1.3

11.96

9.45

mmol/l

6.31

180

316

Other obstetric conditions, not elsewhere classified

630

1474

2.76

105.03

1.6

1.5

6.75

7.10

mmol/l

2.14

624

1450

Endocrine, nutritional and metabolic diseases

840

1750

2.44

104.91

1.4

1.5

9.27

6.37

mmol/l

56.92

801

1741

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

619

1448

2.75

102.85

1.7

1.5

6.74

7.06

mmol/l

1.87

613

1424

Maternal care for other known or suspected fetal problems

432

858

3.23

94.29

1.8

1.4

6.80

7.49

mmol/l

4.24

427

841

Other blood glucose lowering drugs, excl. Insulins

159

273

5.93

88.33

1.2

12.21

7.70

mmol/l

21.15

123

267

Type 1 diabetes, wide definition

257

661

3.95

87.56

1.4

1.5

12.40

6.50

mmol/l

43.81

238

654

Fitting and adjustment of other devices

370

1045

3.16

86.94

1.4

1.2

7.93

9.14

mmol/l

7.45

359

978

Type 1 diabetes, wide definition, subgroup 1

250

637

3.99

86.34

1.4

1.5

12.56

6.49

mmol/l

44.26

231

632

Disorders of lipoprotein metabolism and other lipidaemias

679

1736

2.40

86.22

1.3

10.09

8.89

mmol/l

8.49

628

1621

Pregnancy examination and test

207

252

5.20

82.55

1.8

1.3

6.95

9.54

mmol/l

11.55

207

243

Sub-endpoint used in defining T1D endpoints

340

1102

3.08

78.62

1.4

12.17

8.17

mmol/l

30.29

316

1049

Pure hypercholesterolaemia

592

1606

2.36

73.59

1.3

10.27

9.02

mmol/l

7.51

550

1496

Thiazolidinediones

120

189

6.49

72.82

1.2

1.3

12.47

8.02

mmol/l

16.58

184

Other nutritional deficiencies

752

3389

2.05

71.24

1.4

9.24

7.93

mmol/l

11.71

710

3257

Obesity and other hyperalimentation

718

3302

2.06

70.04

1.4

9.32

7.91

mmol/l

13.00

675

3175

Obesity

715

3290

2.07

69.94

1.4

9.33

7.91

mmol/l

13.03

672

3164

Obesity due to excess calories

563

2537

2.25

68.83

1.4

8.92

7.89

mmol/l

6.36

530

2439

Delivery

358

640

2.98

65.63

1.5

1.2

6.98

9.35

mmol/l

22.73

353

603

Hypertension, essential

613

1571

2.22

64.55

1.3

9.85

8.26

mmol/l

12.18

567

1495

Metabolic disorders

780

2357

2.00

63.70

1.3

9.81

8.36

mmol/l

13.57

727

2234

Gestational diabetes (for exclusion)

581

1843

2.20

62.37

1.7

1.5

7.73

6.87

mmol/l

8.40

562

1819

Alcohol-induced chronic pancreatitis

103

164

6.50

62.11

1.3

1.2

12.42

9.89

mmol/l

3.52

155

Single spontaneous delivery

349

639

2.92

61.79

1.6

1.2

6.94

9.35

mmol/l

22.94

344

602

Persons encountering health services for other counselling and medical advice, not elsewhere classified

967

2835

1.82

58.51

1.4

1.3

8.96

8.41

mmol/l

2.80

924

2693

Acute pancreatitis

203

601

3.43

56.45

1.3

11.01

8.97

mmol/l

5.71

186

567

Hypertension

599

1647

2.06

52.73

1.3

1.4

9.81

8.18

mmol/l

12.35

557

1569

Hypertensive diseases

599

1649

2.06

52.59

1.3

1.4

9.81

8.18

mmol/l

12.40

557

1571

Acute pancreatitis (for exclusion)

203

643

3.20

50.66

1.3

11.01

9.04

mmol/l

5.42

186

606

Supervision of normal pregnancy

214

361

3.43

50.19

1.6

1.3

7.08

9.23

mmol/l

10.34

214

345

Hyperlipidaemia, other/unspecified

285

979

2.64

49.08

1.3

1.2

9.80

9.22

mmol/l

1.32

269

896

Maternal care for other conditions predominantly related to pregnancy

285

1089

2.59

47.76

1.6

1.4

7.08

7.04

mmol/l

0.09

277

1066

Hypertensive diseases (excluding secondary)

451

1195

2.21

47.63

1.3

1.4

9.76

7.82

mmol/l

13.64

423

1150

Disorders of gallbladder, biliary tract and pancreas

808

2875

1.76

45.28

1.3

9.96

8.35

mmol/l

16.39

762

2731

Maternal care related to the fetus and amniotic cavity and possible delivery problems

461

1282

2.13

44.33

1.6

1.4

7.01

7.80

mmol/l

5.73

455

1238

Other symptoms and signs involving the nervous and musculoskeletal systems

400

1887

2.14

43.78

1.3

1.4

7.83

8.42

mmol/l

2.66

395

1785

Maternal care for known or suspected abnormality of pelvic organs

323

917

2.41

42.86

1.8

1.4

6.87

7.63

mmol/l

4.67

316

892

Persons encountering health services in other circumstances, wide

925

2836

1.68

42.71

1.4

1.3

8.91

8.41

mmol/l

2.36

881

2694

STROKE

366

1094

2.27

42.65

1.2

1.3

9.23

8.30

mmol/l

3.07

342

1037

Long labour

310

1118

2.38

42.32

1.5

1.4

6.87

7.45

mmol/l

3.17

305

1090

Abnormal findings on examination of blood, without diagnosis

381

1619

2.15

41.40

1.3

10.53

9.09

mmol/l

5.71

354

1521

Abnormal findings on antenatal screening of mother

171

560

3.14

40.79

1.8

1.4

6.44

6.57

mmol/l

0.35

171

554

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

507

2307

1.92

40.30

1.6

1.5

7.65

7.42

mmol/l

0.75

493

2241

Familial hypercholesterolemia

126

341

3.74

40.27

1.3

1.2

9.10

9.44

mmol/l

0.33

120

311

Other diseases of pancreas

199

4.72

39.71

1.4

1.3

10.87

9.38

mmol/l

1.80

188

Symptoms and signs involving the nervous and musculoskeletal systems

491

2620

1.89

37.89

1.3

8.40

8.61

mmol/l

0.57

479

2474

Other disorders of amniotic fluid and membranes

203

735

2.72

37.32

1.6

1.4

6.62

7.44

mmol/l

4.01

203

721

Heart failure, not strict

498

1784

1.89

35.79

1.2

10.47

9.16

mmol/l

7.39

451

1677

Pregnancy hypertension

458

2205

1.87

33.91

1.5

7.60

7.40

mmol/l

0.62

446

2148

Statin medication

496

1512

1.86

32.68

1.3

1.4

10.17

7.40

mmol/l

28.64

458

1488

Complications of labour and delivery

546

1698

1.80

32.35

1.5

1.4

7.23

7.86

mmol/l

4.50

536

1637

Other disorders of glucose regulation and pancreatic internal secretion

100

271

3.76

32.08

1.4

9.56

8.67

mmol/l

0.79

265

Obesity, other/unspecified

338

1719

1.98

30.39

1.4

9.85

7.79

mmol/l

11.90

314

1655

Diseases of liver

269

1261

2.15

30.15

1.3

11.47

8.95

mmol/l

9.58

244

1180

Diseases of arteries, arterioles and capillaries (FINNGEN)

160

396

2.81

29.32

1.2

1.3

10.55

8.39

mmol/l

5.11

143

372

Acute upper respiratory infections of multiple and unspecified sites

674

3072

1.61

28.23

1.5

1.4

7.92

8.28

mmol/l

1.47

640

2943

Heart failure and antihypertensive medication

140

307

2.98

28.04

1.2

1.3

11.10

7.87

mmol/l

9.44

122

288

Persons encountering health services for specific procedures and health care

888

3481

1.51

27.26

1.3

1.4

8.94

8.14

mmol/l

5.55

839

3343

Gestational [pregnancy-induced] hypertension

306

1570

1.97

26.81

1.6

1.5

7.41

7.19

mmol/l

0.57

301

1539

Sleep apnoea

657

2605

1.60

26.06

1.2

1.3

9.38

8.88

mmol/l

2.00

616

2462

Coronary atherosclerosis

391

1347

1.84

25.89

1.2

10.51

9.49

mmol/l

3.92

354

1251

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

334

1792

1.88

25.73

1.5

8.33

7.54

mmol/l

2.80

323

1737

Persons encountering health services in circumstances related to reproduction

381

1404

1.83

25.08

1.4

1.2

7.61

9.76

mmol/l

20.87

373

1309

Procreative management

225

859

2.17

25.05

1.4

1.3

7.89

9.89

mmol/l

9.42

218

807

Ischaemic heart disease, wide definition

461

1647

1.73

24.80

1.2

10.11

9.35

mmol/l

2.92

421

1533

Obesity related asthma

281

1441

1.96

24.77

1.3

9.53

8.69

mmol/l

2.39

262

1360

Dental caries

202

860

2.23

24.74

1.3

9.67

8.77

mmol/l

1.83

189

805

Caries of dentine

180

763

2.29

23.59

1.3

9.55

8.76

mmol/l

1.36

168

713

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

334

1825

1.82

23.31

1.5

8.33

7.28

mmol/l

4.59

323

1768

Ulcer of lower limb, not elsewhere classified

110

386

2.88

23.22

1.2

11.56

9.47

mmol/l

3.81

100

360

Haemorrhage in early pregnancy

250

1222

2.00

23.21

1.6

1.3

7.25

7.42

mmol/l

0.32

245

1187

Myocardial infarction, strict

275

992

1.97

23.08

1.1

1.2

10.59

9.66

mmol/l

2.57

251

922

Chronic kidney disease

201

912

2.13

22.16

1.2

11.02

9.23

mmol/l

5.73

191

849

Episodal and paroxysmal disorders

885

3093

1.46

22.11

1.4

8.30

8.12

mmol/l

0.63

849

2966

Hard cardiovascular diseases

501

1810

1.64

22.10

1.2

1.3

9.96

9.14

mmol/l

3.17

468

1692

Ischemic heart diseases

496

1803

1.64

22.03

1.2

1.3

9.84

9.31

mmol/l

1.67

459

1689

Atrial fibrillation and flutter with reimbursement

145

359

2.56

21.94

1.3

1.2

9.48

8.63

mmol/l

1.37

137

334

Renal failure

294

1351

1.86

21.63

1.2

10.76

9.41

mmol/l

5.00

277

1260

All chronic kidney diseases

371

1711

1.74

21.39

1.2

1.3

10.48

8.61

mmol/l

11.48

351

1612

Covid-19 confirmed case

293

1624

1.81

20.30

1.3

9.17

8.36

mmol/l

2.17

281

1542

Parasetamol

613

2020

1.54

20.08

1.4

8.61

7.87

mmol/l

3.73

583

1947

Myocardial infarction, without ST-elevation

229

1057

1.96

20.04

1.1

1.2

10.48

9.70

mmol/l

1.79

214

971

Percutaneous Coronary Intervention

458

1713

1.63

19.94

1.2

1.3

9.86

9.37

mmol/l

1.42

423

1601

Coronary revascularization (ANGIO or CABG)

458

1713

1.63

19.84

1.2

1.3

9.88

9.37

mmol/l

1.48

423

1601

Cardiac arrhythmias

403

1544

1.68

19.82

1.4

1.5

8.68

6.37

mmol/l

20.83

387

1535

Cholelithiasis

565

2517

1.54

19.56

1.3

9.38

8.36

mmol/l

6.43

535

2387

Polyhydramnios

231

3.28

19.36

1.8

1.5

7.00

7.77

mmol/l

1.39

225

Myocardial infarction

279

1066

1.84

19.02

1.2

10.65

9.68

mmol/l

2.77

254

991

Nonalcoholic fatty liver disease

329

2.83

18.89

1.3

11.26

8.96

mmol/l

4.24

312

Cholecystectomy

482

2628

1.56

18.68

1.3

9.40

8.61

mmol/l

3.60

459

2485

Cholelithiasis, broad definition with cholecystitis

588

2602

1.51

18.62

1.3

9.42

8.36

mmol/l

6.95

557

2470

Other diseases of biliary tract

200

3.34

18.02

1.3

10.57

9.29

mmol/l

1.35

192

Care involving use of rehabilitation procedures

442

2530

1.58

17.97

1.3

9.10

8.61

mmol/l

1.47

411

2401

Dental pulpitis, including avohilmo

770

3477

1.42

17.95

1.4

8.54

8.14

mmol/l

1.67

741

3328

Sleep apnoea, including avohilmo

687

2861

1.46

17.95

1.2

1.3

9.18

8.68

mmol/l

2.11

644

2717

Cerebrovascular diseases (FINNGEN)

185

631

2.07

17.74

1.2

1.3

9.60

8.21

mmol/l

3.68

172

597

Dialysis, with operation codes

375

2.64

17.67

1.2

1.3

10.88

9.24

mmol/l

2.18

349

Atrial fibrillation and flutter

172

522

2.14

17.66

1.2

1.3

9.60

8.48

mmol/l

1.99

163

490

Disorder of lipoprotein metabolism, unspecified

286

2.89

17.62

1.2

11.20

9.67

mmol/l

1.66

261

Migraine

479

2418

1.55

17.58

1.5

7.58

7.62

mmol/l

0.08

471

2341

Bronchitis

854

3685

1.39

17.52

1.4

8.15

8.35

mmol/l

0.66

812

3533

Major coronary heart disease event excluding revascularizations

331

1284

1.71

17.48

1.2

10.46

9.63

mmol/l

2.48

302

1190

Emergency coronary revascularization (for ACS)

476

1846

1.56

17.35

1.2

9.85

9.41

mmol/l

1.25

438

1722

Other diseases of liver

140

639

2.21

17.08

1.3

11.11

8.79

mmol/l

4.98

122

613

Major coronary heart disease event

472

1824

1.55

16.78

1.2

1.3

9.89

9.38

mmol/l

1.51

435

1703

Malignant neoplasm of pancreas, including Hilmo

225

3.10

16.74

1.2

10.94

9.41

mmol/l

1.34

211

Failed induction of labour

403

2.51

15.89

1.7

1.5

6.56

6.93

mmol/l

1.24

396

Abdominal and pelvic pain

732

2610

1.41

15.72

1.4

8.64

8.31

mmol/l

1.17

694

2490

Contraceptive management

257

1020

1.77

15.61

1.4

1.2

7.48

9.68

mmol/l

16.22

245

955

Other disorders of fluid, electrolyte and acid-base balance

176

856

1.95

15.25

1.2

9.72

8.95

mmol/l

1.33

166

795

Implicit viral Sepsis, including avohilmo

211

1160

1.83

15.13

1.3

9.90

8.52

mmol/l

3.53

204

1102

Cholecystitis

376

2.49

15.02

1.2

1.3

9.08

9.03

mmol/l

0.04

356

Pre-eclampsia or poor fetal growth

324

2007

1.62

14.96

1.5

7.20

7.25

mmol/l

0.11

316

1959

Headache

554

2962

1.45

14.89

1.4

7.96

7.99

mmol/l

0.08

542

2837

Other and unspecified polyneuropathies, also in other diseases

123

566

2.19

14.77

1.3

1.2

11.42

9.46

mmol/l

2.86

115

526

Autoimmune diseases

860

3223

1.36

14.67

1.4

9.35

7.87

mmol/l

14.61

816

3105

Alcohol use disorder, Swedish definition

374

2189

1.56

14.62

1.3

10.74

8.70

mmol/l

10.20

348

2064

Excessive earwax

410

2450

1.52

14.37

1.3

8.72

8.98

mmol/l

0.64

394

2300

Intestinal infectious diseases, including avohilmo, including avohilmo

857

3545

1.35

14.33

1.4

8.77

8.30

mmol/l

2.35

811

3395

Mouth breathing

260

1546

1.69

14.24

1.3

9.08

9.10

mmol/l

0.02

247

1438

Hypertensive heart and/or renal disease

125

420

2.18

14.07

1.2

11.02

8.69

mmol/l

5.30

113

391

Renal tubulo-interstitial diseases

643

3380

1.40

14.02

1.3

1.4

9.70

8.12

mmol/l

14.19

609

3229

Any reimbursement code in KELA

507

1725

1.48

13.93

1.4

1.5

8.85

6.39

mmol/l

30.04

484

1720

All kidney diseases

746

3677

1.36

13.75

1.3

1.4

9.54

8.01

mmol/l

15.62

700

3530

Diseases of pulp and periapical tissues, including avohilmo

779

2967

1.36

13.62

1.4

8.49

8.09

mmol/l

1.86

741

2858

Polyneuropathies and other disorders of the peripheral nervous system

138

688

2.02

13.47

1.3

11.36

9.32

mmol/l

3.23

126

643

Other functional intestinal disorders

319

1841

1.58

13.30

1.3

1.4

8.70

8.49

mmol/l

0.39

308

1740

Transient ischemic attack

282

1380

1.63

13.21

1.3

1.2

9.00

9.50

mmol/l

1.23

266

1285

Dorsalgia

791

3124

1.34

12.89

1.4

8.29

8.17

mmol/l

0.32

756

2998

Angina pectoris

289

1183

1.63

12.89

1.2

10.27

9.65

mmol/l

1.47

268

1100

Hypertensive Heart Disease

109

375

2.21

12.86

1.2

11.14

8.85

mmol/l

4.79

351

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

755

3607

1.35

12.79

1.4

8.74

8.29

mmol/l

1.99

717

3456

Acute renal failure

129

640

2.03

12.78

1.2

10.72

9.35

mmol/l

2.36

121

592

Neurological diseases

679

2484

1.38

12.68

1.4

8.42

7.90

mmol/l

2.51

660

2394

Peripheral artery disease

230

1071

1.70

12.63

1.2

11.11

9.45

mmol/l

5.14

204

1003

Malignant neoplasm of pancreas

176

3.05

12.56

1.2

10.70

9.65

mmol/l

0.61

163

Persons encountering health services for specific procedures, not carried out

330

2.45

12.50

1.2

1.4

12.12

8.22

mmol/l

6.78

319

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

436

2.24

12.43

1.3

1.2

13.34

9.67

mmol/l

6.30

407

Anxiety (asthma-related co-morbidities)

516

2776

1.42

12.36

1.4

8.87

7.78

mmol/l

5.93

495

2666

Hernia of abdominal wall, postoperative

136

691

1.97

12.35

1.2

1.3

9.42

8.63

mmol/l

1.10

130

661

Symptoms and signs involving the digestive system and abdomen

707

2610

1.36

12.32

1.4

8.73

8.31

mmol/l

1.59

676

2490

Alcoholic liver disease

281

2.55

12.11

1.2

13.26

9.52

mmol/l

5.25

264

Periapical abscess

316

2059

1.54

12.03

1.3

9.20

8.78

mmol/l

0.85

295

1937

Pain, not elsewhere classified

218

1300

1.69

11.99

1.3

1.4

8.71

8.06

mmol/l

1.47

208

1225

Antihypertensive medication - note that there are other indications

551

2052

1.41

11.88

1.4

1.6

8.64

6.88

mmol/l

18.87

532

2020

All anxiety disorders

530

2954

1.40

11.73

1.4

8.82

7.88

mmol/l

4.66

509

2841

Any operation in hilmo

5.00

11.64

1.5

1.2

8.53

7.49

mmol/l

0.47

Explicit Sepsis

280

1624

1.58

11.63

1.4

1.3

10.27

8.65

mmol/l

5.57

258

1534

Aplastic and other anaemias

265

1530

1.59

11.46

1.2

1.3

10.39

9.05

mmol/l

3.51

246

1441

Explicit Sepsis, including avohilmo

286

1665

1.56

11.45

1.4

1.3

10.29

8.63

mmol/l

5.90

263

1574

Chronic diseases of tonsils and adenoids

619

2876

1.36

11.34

1.5

1.4

8.04

8.21

mmol/l

0.51

602

2757

Speech therapy

160

889

1.81

11.33

1.2

1.3

9.48

8.96

mmol/l

0.74

152

841

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

289

1159

1.58

11.32

1.4

8.88

7.75

mmol/l

3.37

272

1118

Excessive vomiting in pregnancy

373

2.28

11.18

1.5

1.4

7.46

7.19

mmol/l

0.30

364

Abnormalities of breathing

692

2965

1.34

11.17

1.4

8.55

8.04

mmol/l

2.49

664

2857

Used for control exclusion in common control thyroid runs

799

3071

1.31

11.14

1.4

9.32

7.83

mmol/l

14.39

763

2959

Other soft tissue disorders, not elsewhere classified

722

3096

1.33

11.14

1.4

8.66

8.17

mmol/l

2.04

693

2973

Asthma (mode)

577

2204

1.38

11.09

1.3

1.4

8.81

8.22

mmol/l

2.52

550

2121

Implicit bacterial Sepsis, including avohilmo

263

1385

1.58

11.07

1.2

10.30

9.16

mmol/l

3.03

244

1299

Other diseases of intestine

471

2.12

11.05

1.2

1.3

10.12

9.15

mmol/l

1.26

433

Venous complications and haemorrhoids in pregnancy

4.13

11.03

2.2

1.5

6.51

7.33

mmol/l

0.72

Pain in joint

421

1791

1.45

11.01

1.4

8.17

8.28

mmol/l

0.20

406

1711

General symptoms and signs

811

3112

1.31

10.92

1.3

1.4

8.86

8.11

mmol/l

4.49

781

2978

Mood [affective] disorders

756

3701

1.31

10.82

1.4

9.29

8.16

mmol/l

8.24

722

3540

Mood disorders

757

3703

1.31

10.75

1.4

9.29

8.16

mmol/l

8.25

723

3542

Glomerular disorders in diseases classified elsewhere

375

2.23

10.59

1.3

10.91

9.36

mmol/l

2.16

354

Other and unspecified anaemias

240

1418

1.59

10.58

1.2

1.3

10.66

9.06

mmol/l

4.34

222

1335

Amputation

247

2.53

10.47

1.1

1.3

12.66

9.87

mmol/l

3.85

231

386

2402

1.44

10.41

1.3

1.4

10.73

8.57

mmol/l

12.26

360

2274

Symptoms and signs involving the circulatory and respiratory systems

773

2969

1.31

10.40

1.4

8.28

8.04

mmol/l

0.86

742

2861

Tonsillectomy and adenotomy

500

2523

1.38

10.36

1.5

1.4

7.53

7.79

mmol/l

0.86

490

2445

Other anaemias

241

1429

1.58

10.34

1.2

1.3

10.64

9.06

mmol/l

4.28

223

1346

Depression

711

3635

1.31

10.25

1.3

1.4

9.31

8.13

mmol/l

8.40

679

3477

Atherosclerosis, excluding cerebral and coronary sclerosis

202

960

1.66

10.17

1.2

11.16

9.53

mmol/l

4.51

181

897

Acute upper respiratory infections

738

3395

1.31

10.15

1.4

8.28

8.42

mmol/l

0.42

703

3249

Pre-eclampsia

174

1025

1.71

10.14

1.5

7.53

7.40

mmol/l

0.26

168

997

Chronic periodontitis, complicated

332

2209

1.47

10.12

1.2

1.3

10.10

9.16

mmol/l

2.76

303

2069

Other heart diseases

306

1319

1.51

10.09

1.3

1.4

8.84

7.71

mmol/l

4.23

295

1276

Pre-eclampsia or eclampsia

182

1087

1.69

10.08

1.5

7.76

7.49

mmol/l

0.53

176

1055

Periodontitis

659

3186

1.32

9.99

1.3

9.07

8.62

mmol/l

1.76

616

3036

Other and unspecified iron deficiency

222

1393

1.60

9.98

1.4

1.3

9.88

8.30

mmol/l

4.74

210

1323

Asthma, hospital admission 2, infections

421

2935

1.40

9.96

1.4

8.85

8.29

mmol/l

1.87

405

2806

Asthma-related infections

421

2935

1.40

9.96

1.4

8.85

8.29

mmol/l

1.87

405

2806

Asthma

573

2188

1.35

9.87

1.3

1.4

8.84

8.20

mmol/l

2.89

544

2107

Other headache syndromes

302

2030

1.49

9.85

1.4

8.29

8.03

mmol/l

0.50

292

1937

Neurotic, stress-related and somatoform disorders

665

3494

1.31

9.84

1.4

8.87

8.12

mmol/l

3.84

637

3345

Other neurological diseases

419

2314

1.41

9.82

1.3

8.84

8.99

mmol/l

0.29

398

2171

403

2488

1.41

9.81

1.3

1.4

10.62

8.51

mmol/l

12.16

377

2357

Glomerular diseases

115

604

1.92

9.81

1.3

10.52

9.11

mmol/l

2.40

107

567

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

672

3461

1.31

9.77

1.3

1.4

9.66

8.28

mmol/l

10.22

628

3309

Unspecified mental disorder

296

1993

1.49

9.75

1.3

1.4

8.67

8.22

mmol/l

1.05

278

1909

Asthma, excluding more controls

559

2121

1.36

9.74

1.3

1.4

8.80

8.11

mmol/l

3.23

530

2044

Other bacterial diseases

594

2955

1.33

9.72

1.3

10.41

8.49

mmol/l

15.50

546

2814

Cutaneous abscess, furuncle and carbuncle

198

1222

1.63

9.65

1.2

1.4

9.70

8.31

mmol/l

3.59

184

1166

Caries of dentine, including avohilmo

472

1738

1.39

9.62

1.3

1.4

8.96

8.42

mmol/l

1.88

448

1652

Chronic periodontitis, including avohilmo

654

3180

1.31

9.62

1.3

9.07

8.62

mmol/l

1.71

612

3029

Other anxiety disorders

421

2573

1.40

9.58

1.5

8.71

7.62

mmol/l

5.32

406

2494

Anxiety disorders

667

3506

1.31

9.56

1.4

8.87

8.13

mmol/l

3.78

640

3355

Unstable angina pectoris

175

819

1.68

9.39

1.2

9.85

9.62

mmol/l

0.29

166

757

Continuous positive airway pressure

239

2.34

9.35

1.2

1.3

11.94

6.71

mmol/l

9.01

233

Implicit bacterial Sepsis

228

1250

1.57

9.34

1.2

10.55

9.18

mmol/l

3.63

210

1173

Chronic gastritis

142

809

1.76

9.32

1.2

1.3

10.44

8.89

mmol/l

2.88

133

765

Cardiovascular diseases (excluding rheumatic etc)

536

2276

1.35

9.32

1.4

1.5

8.71

7.20

mmol/l

12.51

514

2228

Bacterial infection, other or unspecified

304

1747

1.47

9.23

1.2

1.3

10.62

8.75

mmol/l

8.22

277

1651

Coronary artery bypass grafting

120

476

1.88

9.17

1.2

10.06

9.80

mmol/l

0.27

111

436

Bacterial infection, other or unspecified, including avohilmo

341

1947

1.44

9.15

1.2

1.3

10.48

8.67

mmol/l

8.83

314

1839

Diseases of the digestive system

271

1803

1.50

9.14

1.3

9.71

8.75

mmol/l

2.34

255

1703

Presence of other devices

143

808

1.75

9.13

1.3

7.74

9.10

mmol/l

6.00

137

767

Abnormalities of heart beat

251

1606

1.52

9.11

1.4

8.06

8.30

mmol/l

0.46

235

1536

334

2321

1.43

8.99

1.4

8.79

8.09

mmol/l

2.30

323

2224

Autoimmune diseases excluding thyroid diseases

756

3205

1.28

8.92

1.4

9.87

7.87

mmol/l

22.20

711

3087

Peripheral artery operations in Hilmo

299

2.25

8.85

1.2

12.72

9.65

mmol/l

4.58

278

Paroxysmal tachycardia

134

629

1.78

8.81

1.4

8.97

7.78

mmol/l

2.28

121

602

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

486

2808

1.35

8.80

1.5

1.4

7.13

7.80

mmol/l

4.97

479

2705

Implicit Sepsis

466

2538

1.36

8.70

1.3

9.61

8.61

mmol/l

4.18

436

2400

Bacterial Sepsis

264

1463

1.50

8.69

1.3

10.65

9.09

mmol/l

5.20

242

1376

Dental caries, including avohilmo

419

1543

1.39

8.68

1.3

1.4

8.97

8.52

mmol/l

1.26

398

1460

Erysipelas, including avohilmo

421

2273

1.37

8.62

1.3

10.34

8.79

mmol/l

8.75

397

2141

Anxiety disorders, excluding more controls

607

2975

1.31

8.59

1.4

8.99

8.07

mmol/l

5.02

581

2841

Gastrointestinal diseases

469

1726

1.37

8.57

1.4

8.41

7.55

mmol/l

4.29

455

1671

Redundant prepuce, phimosis and paraphimosis

118

643

1.81

8.55

1.2

11.33

10.31

mmol/l

1.08

101

588

Asthma (only as main-diagnosis), excluding more controls

513

2121

1.34

8.48

1.4

8.70

8.11

mmol/l

2.38

487

2044

Diseases of oesophagus, stomach and duodenum

728

3377

1.27

8.45

1.3

1.4

9.36

8.26

mmol/l

8.23

681

3228

Low back pain

593

3074

1.30

8.42

1.3

1.4

8.49

8.16

mmol/l

1.05

562

2948

Tramadol

521

2356

1.33

8.41

1.3

1.4

10.10

8.30

mmol/l

13.03

476

2265

Pain in throat and chest

610

2776

1.30

8.40

1.3

1.4

8.93

8.15

mmol/l

4.55

573

2669

Abnormal findings in secretions and smears from cervix uteri vagina vulva

442

2403

1.36

8.36

1.5

7.00

7.46

mmol/l

2.52

436

2337

Hernia of abdominal wall

273

1869

1.47

8.36

1.3

9.04

9.09

mmol/l

0.05

260

1746

Other bacterial diseases, including avohilmo

673

3277

1.28

8.36

1.3

1.4

9.88

8.24

mmol/l

13.87

623

3135

Infections of the skin and subcutaneous tissue

417

3022

1.36

8.35

1.3

1.4

9.51

8.29

mmol/l

5.61

398

2881

Caries of enamel

698

3583

1.28

8.34

1.4

8.83

8.29

mmol/l

2.42

674

3416

COPD/asthma related infections

724

2843

1.28

8.32

1.4

8.40

8.25

mmol/l

0.44

691

2730

COPD/asthma/ILD related infections

724

2843

1.28

8.32

1.4

8.40

8.25

mmol/l

0.44

691

2730

Implicit fungal Sepsis, including avohilmo

202

2.50

8.30

1.1

1.4

9.97

8.90

mmol/l

0.79

194

Injuries to the ankle and foot

556

3642

1.31

8.26

1.4

8.28

8.14

mmol/l

0.32

533

3490

Other/unspecified dorsalgia

257

1721

1.48

8.25

1.4

8.45

8.44

mmol/l

0.02

242

1628

General examination and investigation of persons without complaint and reported diagnosis

457

1749

1.36

8.22

1.4

8.24

7.94

mmol/l

0.75

444

1668

Other special examinations and investigations of persons without complaint or reported diagnosis

467

1749

1.36

8.20

1.4

8.78

7.94

mmol/l

3.64

441

1668

Nutritional anaemias

299

1992

1.43

8.15

1.4

1.3

9.88

8.52

mmol/l

4.55

282

1886

Autoimmune diseases excluding thyroid diseases, strict definition

734

3151

1.27

8.12

1.4

9.85

7.85

mmol/l

21.60

689

3034

Asthma, unspecified (mode)

379

1982

1.38

8.06

1.3

1.4

8.68

8.27

mmol/l

1.14

364

1905

Asthma, unspecified (mode), excluding more controls

372

1926

1.39

7.97

1.4

8.65

8.18

mmol/l

1.35

357

1853

Female infertility

307

1285

1.44

7.88

1.6

1.5

7.00

7.09

mmol/l

0.20

300

1259

Intestinal infectious diseases

677

3975

1.27

7.86

1.4

8.75

8.25

mmol/l

2.18

639

3813

Mood disorders, excluding more controls

669

3090

1.27

7.79

1.3

1.4

9.43

8.12

mmol/l

9.35

638

2948

Asthma (only as main-diagnosis)

515

2188

1.32

7.69

1.3

1.4

8.70

8.20

mmol/l

1.83

489

2107

Spontaneous abortion

389

1911

1.37

7.63

1.6

1.5

7.04

7.47

mmol/l

1.81

379

1859

Other diseases of anus and rectum

178

1132

1.57

7.63

1.3

9.31

8.72

mmol/l

0.98

168

1062

Kela-code for severe mental illness

247

1693

1.46

7.58

1.3

1.4

8.83

8.38

mmol/l

0.89

232

1613

Septicaemia

233

1435

1.48

7.57

1.3

10.89

8.74

mmol/l

7.07

212

1358

Myocardial infarction, with ST-elevation

442

1.93

7.57

1.2

11.03

9.80

mmol/l

1.41

407

Car occupant injured in other and unspecified transport accidents

153

945

1.63

7.57

1.4

7.75

7.95

mmol/l

0.25

146

915

Factors influencing health status and contact with health services

153

458

1.68

7.56

1.4

1.2

9.02

8.94

mmol/l

0.07

147

428

Gastro-oesophageal reflux disease

417

2625

1.34

7.55

1.3

8.90

8.63

mmol/l

0.62

404

2486

Excessive, frequent and irregular menstruation

368

1423

1.39

7.51

1.5

7.30

7.22

mmol/l

0.17

355

1394

Pruritus

467

1.90

7.41

1.3

1.4

9.72

8.18

mmol/l

1.91

454

Iron deficiency anaemia

259

1765

1.44

7.37

1.3

9.85

8.37

mmol/l

5.04

246

1674

Provisional assignment of new diseases of uncertain etiology

383

2819

1.35

7.37

1.3

1.4

9.13

8.09

mmol/l

4.38

368

2696

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

620

2843

1.28

7.36

1.3

1.4

9.18

8.25

mmol/l

4.86

582

2730

620

2843

1.28

7.36

1.3

1.4

9.18

8.25

mmol/l

4.86

582

2730

Codes for special purposes

383

2820

1.35

7.35

1.3

1.4

9.13

8.09

mmol/l

4.36

368

2697

Cardiovascular diseases

540

2205

1.30

7.34

1.4

1.5

8.33

7.09

mmol/l

9.65

524

2160

Lower back pain or/and sciatica

771

3863

1.24

7.32

1.3

1.4

8.52

8.28

mmol/l

0.82

733

3700

Sleep disorders (combined)

782

3290

1.24

7.27

1.3

1.4

8.79

8.11

mmol/l

4.24

746

3154

Viral and other specified intestinal infections, including avohilmo

261

1754

1.44

7.25

1.5

8.11

7.45

mmol/l

1.82

255

1715

Implicit Sepsis, including avohilmo

514

2832

1.30

7.21

1.3

9.50

8.50

mmol/l

4.58

480

2695

Urolithiasis

180

1170

1.54

7.16

1.3

10.01

9.19

mmol/l

1.43

168

1095

Placenta praevia

205

2.37

7.15

1.7

1.4

6.98

7.77

mmol/l

0.90

198

Malaise and fatigue

335

1917

1.38

7.14

1.3

1.4

9.64

8.34

mmol/l

5.65

311

1812

Heart failure,strict

246

1177

1.46

7.14

1.2

10.95

9.34

mmol/l

5.66

221

1102

Pain in limb

610

3053

1.27

7.13

1.3

1.4

8.90

8.15

mmol/l

3.51

583

2932

Nausea and vomiting

175

1104

1.55

7.09

1.4

9.10

8.16

mmol/l

2.17

169

1048

Soft tissue disorders

754

3107

1.24

7.07

1.4

8.07

8.17

mmol/l

0.25

727

2984

Diseases of oral cavity, salivary glands and jaws

308

1125

1.41

7.06

1.3

8.94

8.89

mmol/l

0.06

292

1056

Nonsuppurative otitis media, including avohilmo

305

1899

1.39

7.03

1.6

1.5

7.44

7.45

mmol/l

0.01

299

1857

Schizophrenia or delusion, excluding more controls

211

1408

1.49

6.98

1.3

1.4

9.29

7.92

mmol/l

3.79

201

1339

Poisoning by medicine

172

1115

1.55

6.97

1.3

1.5

10.24

7.75

mmol/l

8.17

161

1082

Disease of hard tissues of teeth, NOS

299

1110

1.41

6.88

1.3

8.78

8.87

mmol/l

0.13

283

1041

Other dorsopathies, not elsewhere classified

746

3126

1.24

6.86

1.4

7.98

8.18

mmol/l

0.68

716

3000

Schizophrenia or delusion

211

1433

1.48

6.84

1.3

1.4

9.29

8.29

mmol/l

2.23

201

1369

Rash and other nonspecific skin eruption

300

2.08

6.81

1.2

1.4

9.24

8.80

mmol/l

0.32

289

Condition for Implicit Sepsis (Organ dysfunction codes)

533

2883

1.28

6.79

1.3

9.48

8.49

mmol/l

4.76

499

2746

Erysipelas

296

1840

1.39

6.74

1.2

1.3

10.78

8.95

mmol/l

8.70

277

1729

Ischaemic Stroke, excluding all haemorrhages

266

1382

1.42

6.69

1.2

10.02

9.54

mmol/l

0.84

248

1282

Mycoses, including avohilmo

656

4014

1.25

6.65

1.3

1.4

8.60

8.29

mmol/l

1.09

618

3851

Acute tubulo-interstitial nephritis

421

2709

1.31

6.65

1.3

1.4

9.43

8.04

mmol/l

7.84

400

2592

Symptoms and signs involving the skin and subcutaneous tissue

484

3556

1.29

6.64

1.3

1.4

8.35

8.41

mmol/l

0.11

461

3393

776

3198

1.23

6.63

1.4

8.48

8.36

mmol/l

0.30

738

3063

Chronic apical periodontitis

793

3631

1.23

6.62

1.3

1.4

8.83

8.15

mmol/l

4.10

737

3499

Asthma (diagnoses ohter than nonallergic)

611

3943

1.25

6.60

1.3

1.4

8.70

8.24

mmol/l

2.03

585

3775

Schizophrenia, schizotypal and delusional disorders

210

1437

1.47

6.58

1.3

1.4

9.31

8.31

mmol/l

2.24

200

1373

Diseases of arteries, arterioles and capillaries

337

1824

1.36

6.51

1.2

10.50

9.28

mmol/l

4.41

309

1714

Migraine with aura

224

1555

1.45

6.51

1.5

7.81

7.32

mmol/l

0.93

217

1514

Corneal ulcer

126

772

1.64

6.50

1.5

1.4

8.92

8.60

mmol/l

0.35

121

736

Adenocarcinoma and ductal carcinoma of pancreas

3.10

6.48

1.2

1.1

11.71

9.46

mmol/l

1.14

Diseases of pulp and periapical tissues and dental caries

362

1374

1.35

6.45

1.3

1.4

8.95

8.54

mmol/l

0.94

342

1306

Retained placenta and membranes, without haemorrhage

485

1.81

6.34

1.6

1.4

7.69

7.88

mmol/l

0.15

465

Gout, strict definition

516

1.77

6.25

1.2

10.96

9.87

mmol/l

1.58

473

Cerebrovascular diseases

368

1919

1.33

6.24

1.2

9.88

9.37

mmol/l

1.21

345

1787

Other septicaemia, including avohilmo

205

1322

1.46

6.24

1.3

10.62

8.71

mmol/l

5.37

187

1250

Complications of procedures, not elsewhere classified

534

3410

1.26

6.20

1.3

1.4

9.00

8.43

mmol/l

2.07

506

3250

Mental and behavioural disorders due to alcohol, excluding acute intoxication

263

1878

1.39

6.20

1.3

10.43

8.91

mmol/l

4.69

246

1766

Gout, idiopatic and unspecified

121

743

1.63

6.20

1.2

10.47

9.80

mmol/l

0.98

112

683

Disorders of breast

354

2346

1.33

6.19

1.4

7.63

7.80

mmol/l

0.41

345

2270

Stroke, excluding SAH

281

1468

1.38

6.14

1.2

9.96

9.58

mmol/l

0.63

262

1364

Alcohol use disorder, ICD-based

245

1750

1.40

6.10

1.3

10.54

8.91

mmol/l

4.90

228

1643

Poisoning by drugs, medicaments and biological substances

182

1232

1.48

6.07

1.4

1.5

10.22

7.78

mmol/l

8.06

170

1194

Stroke, including SAH

296

1554

1.37

6.06

1.2

9.91

9.61

mmol/l

0.48

277

1446

Candidiasis, including avohilmo

230

1629

1.42

6.03

1.3

1.5

9.05

7.80

mmol/l

3.85

208

1576

Heart failure and coronary heart disease

181

849

1.50

5.99

1.2

10.85

9.65

mmol/l

3.14

163

788

Other septicaemia

199

1293

1.45

5.99

1.3

10.60

8.71

mmol/l

5.15

182

1221

Missing teeth due to accident, extraction or parodontitis

334

2239

1.33

5.98

1.2

1.3

9.59

9.20

mmol/l

0.79

308

2099

Other metabolic disorders

472

1.79

5.98

1.3

1.4

8.76

8.01

mmol/l

0.82

461

Sequelae of external causes of morbidity and mortality

147

958

1.54

5.88

1.3

8.62

8.79

mmol/l

0.21

138

912

Radiculopathy

504

1.75

5.87

1.3

9.49

9.21

mmol/l

0.23

473

Hepatic failure, not elsewhere classified

2.85

5.85

1.2

1.4

9.73

9.03

mmol/l

0.34

Diseases of middle ear and mastoid

456

2925

1.28

5.79

1.5

1.4

7.67

7.87

mmol/l

0.54

437

2823

Pain (limb, back, neck, head abdominally)

465

1816

1.29

5.79

1.4

8.63

8.33

mmol/l

0.76

450

1735

Senile cataract

305

1371

1.35

5.72

1.2

10.22

9.42

mmol/l

2.19

274

1286

Hypothyroidism, strict autoimmune

530

2777

1.25

5.68

1.4

8.51

7.69

mmol/l

4.73

502

2676

Cystitis

607

2921

1.24

5.68

1.3

1.4

8.63

7.90

mmol/l

4.01

580

2809

Trochanteric bursitis

467

1.76

5.60

1.3

9.18

8.76

mmol/l

0.36

442

Irregular menses

424

2488

1.28

5.59

1.5

7.68

7.33

mmol/l

1.27

414

2430

Disorders of lens

341

1599

1.32

5.54

1.2

10.15

9.40

mmol/l

2.07

305

1501

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

258

933

1.39

5.48

1.4

8.35

7.70

mmol/l

1.73

252

892

Scabies, including avohilmo

117

737

1.60

5.47

1.4

1.5

7.92

7.86

mmol/l

0.06

112

712

Asthma, including avohilmo

824

3794

1.20

5.47

1.3

1.4

8.68

8.27

mmol/l

1.97

781

3638

Oedema, not elsewhere classified

183

1237

1.45

5.46

1.3

10.04

8.57

mmol/l

3.91

169

1157

Conductive hearing loss, unspecified

278

1.99

5.45

1.5

1.4

8.58

mmol/l

0.00

267

Pregnancy with abortive outcome

513

2129

1.26

5.43

1.5

1.4

7.51

7.56

mmol/l

0.12

501

2071

Benign neoplasm of other and unspecified endocrine glands

435

1.78

5.42

1.2

1.3

8.81

9.06

mmol/l

0.19

415

Necrosis of pulp, including avohilmo

407

3153

1.28

5.41

1.4

8.79

8.29

mmol/l

1.56

394

3004

Asthma-related pneumonia

201

1414

1.42

5.41

1.3

9.69

8.62

mmol/l

2.36

188

1342

Disorders of the thyroid gland

672

3590

1.22

5.39

1.4

8.56

8.12

mmol/l

1.88

641

3441

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

580

3178

1.23

5.38

1.3

1.4

9.49

8.27

mmol/l

7.04

543

3042

Pneumonia, organism unspecified

593

3310

1.23

5.38

1.3

1.4

9.53

8.37

mmol/l

6.46

556

3162

Sciatica+with lumbago

330

2228

1.31

5.35

1.3

1.4

8.79

8.62

mmol/l

0.31

315

2110

Disorders of vestibular function (Vertigo)

246

1754

1.37

5.32

1.4

1.3

9.07

8.93

mmol/l

0.19

232

1649

Myalgia

171

1178

1.46

5.28

1.3

1.4

8.33

8.00

mmol/l

0.43

157

1124

Dysphagia

132

862

1.54

5.28

1.3

9.06

8.82

mmol/l

0.29

126

804

Asthma-related pneumonia or sepsis

201

1421

1.41

5.27

1.3

9.69

8.61

mmol/l

2.39

188

1349

Asthma, hospital admissions 3, pneumonia

201

1421

1.41

5.27

1.3

9.69

8.61

mmol/l

2.39

188

1349

All-cause Heart Failure

262

1340

1.36

5.25

1.2

10.98

9.52

mmol/l

5.23

237

1251

Dental operations

316

1220

1.33

5.24

1.3

8.99

9.11

mmol/l

0.19

298

1146

Other bacterial intestinal infections

606

1.64

5.22

1.3

8.64

8.87

mmol/l

0.21

577

Polyuria

121

778

1.56

5.20

1.3

9.74

9.12

mmol/l

0.74

116

727

Calculus of kidney and ureter

159

1084

1.47

5.18

1.3

9.88

9.14

mmol/l

1.14

147

1013

Injuries to the neck

174

1208

1.45

5.17

1.4

7.99

8.03

mmol/l

0.03

169

1161

Abnormal serum enzyme levels

153

998

1.48

5.17

1.3

1.2

9.31

9.60

mmol/l

0.33

140

923

Haemorrhage, not elsewhere classified

2.82

5.15

1.2

1.3

11.22

9.40

mmol/l

0.75

Genitourinary diseases

378

1463

1.30

5.14

1.3

1.4

8.97

8.33

mmol/l

1.67

366

1404

Heart failure, strict

264

1357

1.35

5.11

1.2

10.92

9.53

mmol/l

4.83

239

1265

Other diseases of hard tissues of teeth

291

1123

1.34

5.09

1.3

8.88

8.90

mmol/l

0.01

275

1054

Other bacterial intestinal infections, including avohilmo

139

926

1.51

5.09

1.3

1.4

8.36

8.50

mmol/l

0.16

133

886

Dyspnoea

568

3354

1.22

4.98

1.3

1.4

9.14

8.45

mmol/l

3.19

540

3188

Enlarged lymph nodes

591

1.63

4.97

1.3

1.4

8.16

8.30

mmol/l

0.14

559

Diverticular disease of intestine

351

1688

1.30

4.94

1.2

9.39

9.46

mmol/l

0.10

320

1569

Bacterial intestinal infections, IBD co-morbidities

600

1.62

4.93

1.3

8.83

8.95

mmol/l

0.10

573

Pediculosis, acariasis and other infestations, including avohilmo

128

845

1.52

4.91

1.4

1.5

8.23

8.03

mmol/l

0.21

123

818

Dorsopathies

739

3129

1.20

4.90

1.4

7.92

8.18

mmol/l

1.00

711

3003

Other and unspecified effects of external causes

204

1473

1.39

4.88

1.3

1.5

8.23

7.93

mmol/l

0.49

196

1422

Gout, unspecified

602

1.62

4.87

1.1

1.2

10.55

9.77

mmol/l

0.97

554

Examination and observation for other reasons

394

1744

1.28

4.85

1.4

9.90

7.94

mmol/l

10.27

371

1663

Gout

136

779

1.50

4.84

1.2

10.51

9.88

mmol/l

0.97

126

724

Gout, FINNGEN

136

906

1.50

4.83

1.2

10.51

9.71

mmol/l

1.39

126

834

Presbycusis

294

1.89

4.81

1.1

1.2

9.93

9.89

mmol/l

0.02

270

Female infertility, cervical, vaginal, other or unspecified origin

262

1252

1.34

4.75

1.6

1.5

7.10

7.11

mmol/l

0.01

255

1226

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

248

1834

1.34

4.74

1.5

7.61

7.35

mmol/l

0.53

242

1787

Sequelae of cerebrovascular disease

162

962

1.44

4.70

1.2

9.86

9.34

mmol/l

0.78

154

896

Follow-up examination after treatment for conditions other than malignant neoplasms

306

1561

1.31

4.68

1.4

9.09

7.75

mmol/l

4.77

288

1495

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

103

2.57

4.67

1.5

1.6

6.99

7.77

mmol/l

0.83

103

L04AA Selective immunosuppressants

130

872

1.50

4.65

1.2

1.3

9.49

8.61

mmol/l

1.12

121

834

Benign neoplasm: Adrenal gland

198

2.08

4.65

1.2

1.3

10.36

9.60

mmol/l

0.42

188

Hypothyreosis and Thyroxine purchase for inclusion criteria

640

3494

1.20

4.61

1.4

8.55

8.06

mmol/l

2.22

610

3353

Strabismus

175

1242

1.41

4.58

1.5

1.4

8.20

8.11

mmol/l

0.10

166

1197

Localized swelling, mass and lump of skin and subcutaneous tissue

187

1346

1.39

4.58

1.3

8.49

8.57

mmol/l

0.09

182

1272

Carpal tunnel syndrome

342

2321

1.28

4.58

1.3

8.71

8.74

mmol/l

0.05

323

2189

Varicose veins

294

1702

1.31

4.56

1.3

1.2

8.49

9.14

mmol/l

1.91

282

1591

Symptoms and signs involving the urinary system

425

2572

1.25

4.55

1.3

9.35

8.79

mmol/l

1.68

406

2417

Misadventures to patients during surgical and medical care

513

1.65

4.53

1.3

9.51

8.72

mmol/l

0.66

488

Disorders of sclera, cornea, iris and ciliary body

333

2611

1.28

4.53

1.4

8.77

8.51

mmol/l

0.57

319

2471

Chronic lower respiratory diseases

834

3742

1.17

4.52

1.4

8.68

8.25

mmol/l

2.16

786

3595

All influenza

150

1042

1.44

4.49

1.3

1.4

9.06

8.61

mmol/l

0.64

141

991

Sequelae with surgical and medical care as external cause

107

694

1.55

4.49

1.3

8.39

9.05

mmol/l

1.08

101

662

Amputation of toe

181

2.11

4.48

1.1

1.2

12.83

9.96

mmol/l

2.43

170

Hypothyroidism, other/unspecified

621

3405

1.20

4.47

1.4

8.52

8.04

mmol/l

2.08

592

3267

Spondylosis

271

1612

1.32

4.46

1.2

9.08

9.47

mmol/l

0.71

256

1500

Other and unspecified nonorganic psychotic disorders

132

897

1.48

4.45

1.4

9.74

8.03

mmol/l

3.14

127

869

Visual disturbances

294

2275

1.30

4.45

1.4

8.06

8.47

mmol/l

1.20

272

2168

Malignant neoplasm of digestive organs, including Hilmo

208

1119

1.37

4.42

1.2

10.72

9.41

mmol/l

3.18

185

1051

Adverse effects, not elsewhere classified

140

964

1.46

4.42

1.3

1.5

8.44

7.85

mmol/l

0.97

134

933

Gingivitis and periodontal diseases

605

2595

1.21

4.38

1.3

1.4

8.77

8.50

mmol/l

0.78

568

2474

Other disorders of skin and subcutaneous tissue

414

2819

1.24

4.31

1.3

9.50

8.69

mmol/l

3.03

388

2671

Pain associated with micturition

422

1.69

4.27

1.3

1.4

8.65

8.62

mmol/l

0.02

407

Explicit bacterial Sepsis

318

1.80

4.27

1.5

1.3

11.30

8.83

mmol/l

2.58

303

Streptococcal septicaemia

261

1.89

4.25

1.3

11.87

8.91

mmol/l

2.91

250

Other gastritis (incl. Duodenitis)

108

712

1.52

4.23

1.2

1.3

11.34

8.82

mmol/l

5.27

100

672

Keratitis

219

1640

1.34

4.22

1.4

8.81

8.46

mmol/l

0.62

210

1550

Other diseases of arteries and capillaries

262

1.88

4.21

1.2

1.4

9.73

9.26

mmol/l

0.25

248

Nerve, nerve root and plexus disorders

682

3462

1.18

4.19

1.3

1.4

9.26

8.34

mmol/l

5.66

644

3303

Viral and other specified intestinal infections

182

1294

1.38

4.18

1.5

8.07

7.49

mmol/l

1.11

177

1272

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

304

2352

1.28

4.18

1.4

1.5

8.14

7.74

mmol/l

0.96

296

2276

Triptan medication for migraine, single purchase ok

551

3102

1.20

4.18

1.5

1.4

7.88

8.06

mmol/l

0.50

536

2974

Migraine, single triptan purchase ok & required. ICD-code if available is included

551

3102

1.20

4.18

1.5

1.4

7.88

8.06

mmol/l

0.50

536

2974

Excluding asthma or asthma-COPD overlap

534

2207

1.21

4.17

1.4

8.58

8.20

mmol/l

1.15

505

2125

Other pulmonary diagnosis

534

2207

1.21

4.17

1.4

8.65

8.20

mmol/l

1.45

505

2125

Disorders of skin appendages

361

2875

1.25

4.15

1.4

8.51

7.95

mmol/l

1.87

343

2765

Diseases of inner ear

278

2061

1.29

4.15

1.4

1.3

9.14

9.03

mmol/l

0.16

261

1941

Visual disturbances and blindness

310

2436

1.27

4.14

1.4

8.13

8.54

mmol/l

1.21

285

2321

Acute bronchitis

240

1790

1.32

4.14

1.3

1.4

9.07

8.33

mmol/l

1.63

228

1696

Other cataract

208

1145

1.35

4.13

1.2

9.95

9.28

mmol/l

1.07

182

1080

Bipolar affective disorders

146

1030

1.42

4.08

1.4

1.5

8.74

7.46

mmol/l

2.83

134

999

Other acute lower respiratory infections

330

2495

1.26

4.06

1.3

1.4

8.99

8.37

mmol/l

1.66

314

2372

Other disorders of kidney and ureter

383

1.71

4.05

1.3

10.34

9.53

mmol/l

0.63

360

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

340

2354

1.26

4.05

1.3

9.72

9.07

mmol/l

1.78

320

2207

Other diseases of upper respiratory tract

721

3195

1.18

4.04

1.4

8.60

8.39

mmol/l

0.65

682

3057

Benign paroxysmal vertigo

147

1040

1.42

4.04

1.4

1.3

9.21

8.89

mmol/l

0.41

141

984

Other enthesopathies

168

1216

1.39

4.03

1.3

8.68

8.74

mmol/l

0.07

159

1142

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

647

3645

1.18

4.01

1.3

1.4

9.40

8.28

mmol/l

6.80

606

3491

Glaucoma suspect

169

1225

1.38

4.01

1.3

1.2

8.90

9.22

mmol/l

0.46

157

1152

Dermatitis and eczema

753

3814

1.17

4.01

1.4

8.57

8.34

mmol/l

0.78

713

3656

Alcohol dependence

138

967

1.43

4.00

1.2

1.3

11.18

9.20

mmol/l

3.93

128

894

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

122

836

1.47

4.00

1.3

1.5

10.62

7.70

mmol/l

7.71

115

805

Hypokalaemia

325

1.76

3.99

1.2

1.3

9.75

8.94

mmol/l

0.60

306

Acute and transient psychotic disorders

400

1.68

3.99

1.2

1.3

9.40

8.70

mmol/l

0.45

381

Lesion of ulnar nerve

485

1.62

3.97

1.4

1.3

9.02

9.11

mmol/l

0.06

459

Gastroduodenal ulcer

113

761

1.48

3.96

1.3

1.2

10.27

9.01

mmol/l

1.98

106

716

Presence of cardiac and vascular implants and grafts

201

1097

1.35

3.96

1.1

1.2

9.78

9.77

mmol/l

0.01

190

1024

GI-bleeding

150

1069

1.41

3.95

1.3

9.55

9.08

mmol/l

0.57

137

1004

Streptococcal septicaemia, including avohilmo

268

1.84

3.94

1.3

11.87

8.95

mmol/l

2.86

257

Other disorders of penis

276

1.82

3.89

1.1

1.2

10.08

10.07

mmol/l

0.00

251

Explicit bacterial Sepsis, including avohilmo

328

1.75

3.88

1.5

1.3

11.30

8.89

mmol/l

2.48

312

Other extrapyramidal and movement disorders in other diseases

129

899

1.44

3.87

1.3

9.09

8.85

mmol/l

0.24

120

850

Other diseases of blood and blood-forming organs, wide

114

776

1.47

3.87

1.3

9.91

8.98

mmol/l

1.51

109

738

Rheumatism, unspecified

419

1.65

3.86

1.3

9.57

8.69

mmol/l

0.67

396

Soft tissue disorders related to use, overuse and pressure

143

1016

1.41

3.85

1.2

1.3

8.80

9.09

mmol/l

0.31

136

943

Diabetic nephropathy, excluding more controls

138

793

1.43

3.79

1.1

1.3

12.06

10.70

mmol/l

2.86

129

712

Other diseases of intestines

744

3559

1.17

3.78

1.3

1.4

8.56

8.12

mmol/l

1.97

712

3418

Asthma, hospital admissions , main diagnosis only

544

3983

1.19

3.75

1.4

8.58

8.23

mmol/l

1.18

518

3821

Influenza and pneumonia

723

3830

1.17

3.74

1.3

1.4

9.24

8.12

mmol/l

7.90

681

3679

Acute sinusitis

365

2691

1.24

3.74

1.4

8.01

8.10

mmol/l

0.16

350

2578

Diseases of the skin and subcutaneous tissue

670

2862

1.18

3.73

1.4

8.89

8.08

mmol/l

4.88

637

2752

Syncope and collapse

260

1691

1.29

3.71

1.3

1.4

9.32

8.43

mmol/l

2.21

247

1600

Flat foot [pes planus] (acquired)

318

1.74

3.71

1.3

8.13

8.69

mmol/l

0.47

310

Peripheral arterial reconstruction

424

1.63

3.70

1.2

11.47

9.68

mmol/l

1.91

396

Other antidepressants

684

2981

1.17

3.69

1.3

1.4

9.33

8.07

mmol/l

8.76

647

2869

Exclusions for E4_PCOS_BROAD

103

695

1.49

3.66

1.3

1.4

9.31

8.35

mmol/l

1.06

665

Disorders of other endocrine glands

284

2213

1.27

3.65

1.4

8.81

8.08

mmol/l

1.82

269

2120

Pneumonias (Asthma/COPD co-morbidities)

667

3729

1.17

3.62

1.3

1.4

9.35

8.21

mmol/l

7.32

626

3574

Conjunctivitis (acute, non atopic), including avohilmo

673

3480

1.17

3.60

1.4

1.3

8.39

8.45

mmol/l

0.13

649

3319

Emotionally unstable personality disorder

119

832

1.44

3.57

1.4

1.5

9.28

7.28

mmol/l

4.98

113

817

Persons with potential health hazards related to communicable diseases

310

2466

1.25

3.56

1.4

1.5

7.41

7.57

mmol/l

0.35

295

2403

Diplopia

429

1.62

3.55

1.3

8.17

9.12

mmol/l

1.18

411

COPD related to multimorbidity

168

1048

1.36

3.54

1.2

10.29

9.59

mmol/l

1.08

149

977

Other strabismus

147

1063

1.38

3.53

1.5

1.4

8.10

7.97

mmol/l

0.13

141

1029

Personality disorders

211

1618

1.31

3.53

1.3

1.5

9.43

7.61

mmol/l

6.97

202

1570

Appendectomy

430

3398

1.21

3.53

1.4

8.30

8.24

mmol/l

0.12

416

3244

Mental and behavioural disorders due to alcohol

298

2269

1.25

3.52

1.3

1.4

10.39

8.65

mmol/l

6.80

281

2145

COPD differential diagnosis

525

2206

1.19

3.52

1.4

8.59

8.22

mmol/l

1.12

497

2123

Benign neoplasm of colon, rectum, anus and anal canal

298

2011

1.25

3.51

1.2

10.54

9.37

mmol/l

3.41

276

1875

Mycoses

162

1196

1.36

3.51

1.2

1.3

9.14

8.45

mmol/l

1.16

149

1139

Transport accidents

352

2383

1.23

3.50

1.4

8.33

7.96

mmol/l

0.81

337

2296

Shoulder lesions

408

2009

1.22

3.49

1.3

8.95

9.00

mmol/l

0.06

375

1891

Other heart diseases, wide

598

3080

1.18

3.48

1.3

1.4

8.93

8.22

mmol/l

3.53

571

2950

ILD differential diagnosis

524

2204

1.19

3.48

1.4

8.59

8.22

mmol/l

1.12

496

2121

Malignant neoplasm of digestive organs

181

1036

1.34

3.45

1.2

10.65

9.39

mmol/l

2.67

164

973

Psoriasis vulgaris

102

697

1.47

3.44

1.3

10.91

8.87

mmol/l

3.21

657

All pneumoniae

669

3739

1.16

3.43

1.3

1.4

9.38

8.20

mmol/l

7.77

628

3585

Other symptoms and signs involving cognitive functions and awareness

228

1568

1.29

3.43

1.2

1.3

9.79

9.15

mmol/l

1.14

213

1472

Secondary hypertension

191

1.92

3.42

1.2

1.4

10.32

8.09

mmol/l

1.53

184

Vitamin B12 deficiency anaemia

259

1.78

3.41

1.4

1.3

9.67

9.33

mmol/l

0.15

246

Superficial injury of wrist and hand

152

1117

1.37

3.41

1.4

1.5

8.11

7.90

mmol/l

0.28

146

1085

Substance abuse

350

2655

1.23

3.41

1.3

1.4

10.20

8.53

mmol/l

7.63

329

2518

Complications of surgical and medical care, not elsewhere classified

631

3611

1.17

3.39

1.3

1.4

8.98

8.38

mmol/l

2.68

600

3447

Other sexually transmitted chlamydial diseases, including avohilmo

822

0.59

3.37

1.6

8.30

6.97

mmol/l

1.49

812

Allergic asthma (mode)

174

1278

1.33

3.33

1.4

1.5

8.70

7.57

mmol/l

2.88

166

1245

Dermatophytosis, including avohilmo

409

3338

1.20

3.28

1.3

1.4

8.57

8.48

mmol/l

0.16

390

3177

Allergic asthma (mode), excluding more controls

174

1281

1.33

3.28

1.4

1.5

8.70

7.54

mmol/l

3.00

166

1247

Rotator cuff syndrome

310

1721

1.24

3.28

1.2

1.3

9.16

9.30

mmol/l

0.20

288

1612

Suicide or other Intentional self-harm

162

1211

1.34

3.27

1.3

1.4

10.36

7.97

mmol/l

7.19

153

1163

Any death

195

1771

0.77

3.27

1.1

1.2

11.29

9.50

mmol/l

4.35

179

1650

Other spirochaetal diseases

1392

0.70

3.21

1.3

9.74

8.75

mmol/l

1.16

1313

Diabetic neuropathy

100

689

1.45

3.20

1.3

1.2

12.98

11.12

mmol/l

2.37

612

Liveborn infants according to place of birth

6.60

3.20

1.4

1.3

7.21

10.74

mmol/l

—

Other disorders of lacrimal gland

199

1537

1.30

3.19

1.3

8.66

8.52

mmol/l

0.19

194

1448

Spirochaetal infections, other/unspecified, including avohilmo

1389

0.70

3.18

1.2

1.3

9.78

8.74

mmol/l

1.25

1310

Diabetic nephropathy

140

1016

1.37

3.18

1.1

1.3

12.11

11.15

mmol/l

1.59

131

908

Disturbances of skin sensation

186

1425

1.31

3.17

1.4

7.85

8.00

mmol/l

0.19

179

1371

Functional dyspepsia

151

1123

1.35

3.16

1.4

8.92

8.16

mmol/l

1.50

139

1077

Extrapyramidal and movement disorders

187

1434

1.31

3.16

1.2

1.3

9.40

8.98

mmol/l

0.58

174

1346

Lyme disease

1375

0.70

3.16

1.2

1.3

9.78

8.75

mmol/l

1.21

1296

Lyme disease, including avohilmo

1375

0.70

3.16

1.2

1.3

9.78

8.75

mmol/l

1.21

1296

AV-block

403

1.55

3.15

1.1

1.2

9.88

9.33

mmol/l

0.47

378

Benign neoplasms

709

3352

1.15

3.15

1.3

1.4

8.49

8.12

mmol/l

1.43

673

3227

Selective serotonin reuptake inhibitors

664

2984

1.16

3.14

1.3

1.4

9.24

8.07

mmol/l

7.42

619

2871

Umbilical hernia

152

1133

1.35

3.14

1.2

1.3

9.18

9.24

mmol/l

0.05

143

1070

Open wound of lower leg

580

1.49

3.14

1.3

1.4

10.26

8.57

mmol/l

2.38

551

Adenocarcinoma of pancreas

2.56

3.13

1.1

11.90

9.25

mmol/l

1.01

Malignant neoplasm of breast, HER2-negative

117

1047

0.72

3.09

1.2

1.3

9.07

8.59

mmol/l

0.54

109

999

Other spirochaetal diseases, including avohilmo

101

1424

0.71

3.05

1.3

9.73

8.72

mmol/l

1.26

1344

Superficial injury of head

132

968

1.37

3.02

1.3

1.4

9.97

8.45

mmol/l

2.81

123

929

Personality disorders, excluding more controls

211

1652

1.28

3.02

1.3

1.5

9.43

7.31

mmol/l

9.14

202

1598

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

569

1.48

3.00

1.2

1.4

10.80

8.74

mmol/l

2.99

544

Other reaction to severe stress, and adjustment disorders

278

2252

1.24

2.99

1.4

1.5

8.53

7.58

mmol/l

3.20

273

2181

Malignant neoplasm of breast

118

1048

0.72

2.99

1.2

1.3

9.07

8.59

mmol/l

0.55

110

1000

Unspecified haematuria

196

1238

1.29

2.98

1.2

1.3

10.08

9.32

mmol/l

1.48

189

1149

Preterm labour and delivery

145

1083

1.34

2.97

1.5

1.4

7.55

8.00

mmol/l

1.04

138

1042

Acute pharyngitis

121

870

1.38

2.97

1.5

8.30

7.54

mmol/l

1.24

113

846

Early onset COPD, excluding more controls

644

1.45

2.97

1.2

10.13

9.44

mmol/l

0.74

607

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

169

1.91

2.95

1.5

1.3

6.93

7.79

mmol/l

1.18

162

Candidiasis

580

1.47

2.95

1.2

1.4

9.83

8.27

mmol/l

2.19

564

Any gastric operation

579

2498

1.16

2.94

1.4

8.57

7.65

mmol/l

5.45

556

2433

GASTRO-related operations

579

2498

1.16

2.94

1.4

8.57

7.65

mmol/l

5.45

556

2433

Valvular heart disease excluding rheumatic fever

209

1167

1.28

2.93

1.2

1.3

8.86

9.19

mmol/l

0.53

195

1089

Open wound of ankle and foot

396

1.57

2.93

1.4

10.33

8.48

mmol/l

1.83

380

Psoriasis

151

1138

1.33

2.92

1.3

10.52

8.76

mmol/l

3.90

141

1066

Pulmonary embolism

129

949

1.36

2.92

1.2

1.3

9.82

9.08

mmol/l

0.94

121

896

Pulmonary heart disease

129

950

1.36

2.90

1.2

1.3

9.82

9.10

mmol/l

0.90

121

897

Other diseases of the digestive system

144

1080

1.34

2.88

1.3

9.72

9.08

mmol/l

0.81

131

1015

Substance abuse, excluding more controls

350

2431

1.20

2.88

1.3

1.4

10.20

8.17

mmol/l

10.71

329

2307

Acute posthaemorrhagic anaemia

2.26

2.87

1.2

1.3

7.43

9.27

mmol/l

1.27

Non-selective monoamine reuptake inhibitors

174

1286

1.30

2.87

1.2

1.3

10.22

8.84

mmol/l

2.90

158

1213

Diabetic retinopathy, strict definition

1155

0.70

2.86

1.2

1.3

11.91

10.92

mmol/l

1.13

1042

Cerebral palsy and other paralytic syndromes

360

1.59

2.83

1.3

1.4

9.97

8.90

mmol/l

1.05

347

Mental and behavioural disorders due to psychoactive substance use

355

2718

1.20

2.79

1.3

1.4

10.25

8.50

mmol/l

8.30

334

2581

Non-rheumatic valve diseases

207

1162

1.27

2.79

1.2

1.3

8.84

9.19

mmol/l

0.57

193

1084

Persistent mood disorders

113

823

1.38

2.76

1.3

1.4

9.65

7.99

mmol/l

3.15

104

793

Substance use, excluding alcohol

118

866

1.37

2.75

1.2

1.4

11.03

8.28

mmol/l

5.68

108

829

COPD (mode)

132

765

1.35

2.73

1.2

10.12

9.48

mmol/l

0.75

115

720

Irritable bowel syndrome

176

1370

1.29

2.72

1.3

1.4

8.42

7.87

mmol/l

1.19

169

1310

Pulmonary heart disease, diseases of pulmonary circulation

139

1047

1.33

2.72

1.2

9.98

9.09

mmol/l

1.29

128

984

Disorders of ocular muscles, binocular movement, accommodation and refraction

326

2692

1.20

2.71

1.4

7.97

8.00

mmol/l

0.06

314

2583

Diarrhoea and gastroenteritis of presumed infectious origin

459

3512

1.17

2.69

1.4

9.15

8.17

mmol/l

4.54

432

3370

Other diseases of urinary system

652

3204

1.14

2.68

1.4

8.71

8.12

mmol/l

2.82

616

3065

Other viral diseases, not elsewhere classified, including avohilmo

183

1426

1.28

2.68

1.5

1.4

7.89

7.93

mmol/l

0.06

177

1371

Malignant neoplasm of breast, HER2-negative, including Hilmo

124

1065

0.74

2.67

1.3

8.93

8.56

mmol/l

0.41

115

1017

Disorders of adult personality and behaviour

218

1747

1.25

2.67

1.3

1.5

9.29

7.62

mmol/l

6.29

209

1696

Malignant neoplasm of breast, including Hilmo

124

1064

0.74

2.66

1.3

8.93

8.56

mmol/l

0.41

115

1016

Trigeminal neuralgia

183

1.81

2.65

1.2

1.4

7.22

9.08

mmol/l

2.75

175

Other menopausal disorders

588

0.68

2.62

1.3

8.02

8.43

mmol/l

0.38

561

Deviated nasal septum

161

1244

1.30

2.62

1.2

1.3

9.17

9.23

mmol/l

0.06

147

1162

Coagulation defects, purpura and other haemorrhagic conditions

105

763

1.38

2.62

1.4

9.24

8.49

mmol/l

0.83

100

730

Diabetic retinopathy

214

1654

0.80

2.61

1.2

1.3

11.79

11.19

mmol/l

0.95

188

1493

Pedestrian injured in transport accident

244

1.69

2.60

1.3

1.4

10.35

8.67

mmol/l

1.23

234

Hypertrophy of breast in women and men

109

799

1.37

2.58

1.3

1.4

8.03

8.21

mmol/l

0.22

104

763

Sarcoidosis

401

1.53

2.58

1.4

1.3

8.93

9.45

mmol/l

0.50

377

Visual field defects

237

1.70

2.57

1.1

1.4

9.01

9.33

mmol/l

0.19

230

Opioids

687

3125

1.14

2.56

1.4

8.65

7.84

mmol/l

4.99

645

3032

Diseases of the ear and mastoid process

778

3460

1.13

2.56

1.5

1.4

8.39

8.29

mmol/l

0.28

743

3321

Congenital malformations of the urinary system, including avohilmo

215

1.73

2.56

1.3

1.4

7.92

8.33

mmol/l

0.31

208

Papulosquamous disorders

202

1614

1.25

2.55

1.3

9.71

8.81

mmol/l

1.80

189

1514

Other disorders of urethra and urinary system

457

2733

1.16

2.53

1.4

8.83

7.90

mmol/l

4.60

434

2633

Diagnoses used for exclusion with ILD

111

819

1.36

2.53

1.3

10.13

9.17

mmol/l

1.28

101

771

DVT of lower extremities and pulmonary embolism

185

1461

1.26

2.48

1.2

1.3

9.45

9.22

mmol/l

0.27

173

1366

Benign neoplasm: Colon, unspecified

105

771

1.37

2.47

1.2

10.42

9.45

mmol/l

1.03

713

Delirium, not induced by alcohol and other psychoactive substances

278

1.62

2.46

1.2

10.44

9.54

mmol/l

0.46

261

Specific personality disorders

177

1403

1.27

2.42

1.3

1.5

9.41

7.58

mmol/l

5.85

169

1365

Other sexually transmitted chlamydial diseases

467

0.55

2.42

1.6

8.67

7.15

mmol/l

1.01

461

Status post-ami

481

1.41

2.41

1.1

1.2

10.43

9.75

mmol/l

0.84

442

First line medication for Crohn's disease

748

3580

1.12

2.41

1.3

1.4

8.62

8.12

mmol/l

2.46

705

3444

Diseases of male genital organs

219

885

1.25

2.41

1.2

10.34

mmol/l

0.00

206

812

Complications specific to multiple gestation

4.25

2.38

1.9

1.5

6.43

8.75

mmol/l

—

Benign neoplasm: Colon

240

1847

1.22

2.37

1.2

10.25

9.43

mmol/l

1.67

221

1719

Benign neoplasm: Rectosigmoid junction

2.08

2.37

1.1

1.3

10.40

9.96

mmol/l

0.18

Heart failure and bmi 25plus

139

709

1.31

2.36

1.2

11.74

9.83

mmol/l

4.29

125

657

Any event in cancer register

471

3165

0.87

2.35

1.3

1.4

9.17

8.22

mmol/l

4.38

441

3035

Other disorders of eye and adnexa

575

1.41

2.35

1.3

1.4

8.00

8.28

mmol/l

0.19

557

Thyroiditis, ILD-related definition

484

1.45

2.35

1.4

8.10

7.96

mmol/l

0.11

469

Examination and encounter for administrative purposes

244

1.65

2.34

1.4

1.3

8.26

8.68

mmol/l

0.32

231

Polycystic ovarian syndrome, consortium definition

536

2687

1.15

2.33

1.5

1.4

7.73

7.49

mmol/l

0.79

519

2619

Non-allergic asthma (mode)

103

755

1.35

2.33

1.2

1.4

8.63

8.21

mmol/l

0.61

729

Other enthesopathy of foot (+metatarsalgia)

387

1.50

2.32

1.2

1.4

9.09

8.24

mmol/l

0.76

374

Congenital malformations of the urinary system

199

1.72

2.32

1.4

7.91

8.47

mmol/l

0.42

193

Abnormalities of gait and mobility

331

1.55

2.31

1.3

12.43

9.54

mmol/l

3.77

307

Codeine

644

3078

1.13

2.31

1.3

1.4

9.11

7.86

mmol/l

8.87

599

2985

Haemorrhoids and perianal venous thrombosis

169

1330

1.26

2.31

1.4

1.3

8.28

8.78

mmol/l

0.88

164

1246

Metatarsalgia

348

1.53

2.29

1.2

1.4

9.23

8.26

mmol/l

0.83

336

Placental disorders

2.60

2.29

1.7

1.5

8.60

7.84

mmol/l

0.12

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

654

1.38

2.28

1.2

1.4

10.65

8.72

mmol/l

2.85

625

Benign neoplasm of other and ill-defined parts of digestive system

555

1.41

2.25

1.3

9.35

9.20

mmol/l

0.12

525

Follicular cysts of skin and subcutaneous tissue

716

1.36

2.25

1.2

1.3

9.91

8.77

mmol/l

1.49

679

Non-allergic asthma (mode), excluding more controls

103

760

1.35

2.25

1.2

1.4

8.63

8.18

mmol/l

0.67

732

Perforation of tympanic membrane

342

1.53

2.24

1.5

1.4

9.23

8.58

mmol/l

0.56

329

Sequelae of other external causes

179

1.74

2.22

1.2

1.4

9.98

8.75

mmol/l

0.78

171

Alcohol withdrawal state with delirium

179

1.74

2.22

1.2

14.35

10.11

mmol/l

2.72

170

Other and unspecified dermatitis

308

2608

1.18

2.21

1.3

1.4

8.63

8.36

mmol/l

0.57

289

2489

Symptoms and signs involving cognition, perception, emotional state and behaviour

595

3517

1.13

2.21

1.3

1.4

8.98

8.41

mmol/l

2.50

559

3358

Disorders of lacrimal system

234

1904

1.21

2.17

1.4

1.3

8.42

8.54

mmol/l

0.19

228

1798

Struck by thrown, projected or falling objec

188

1.71

2.17

1.2

1.5

7.60

8.78

mmol/l

0.86

182

Anosmia

2.83

2.16

1.0

1.5

9.62

6.62

mmol/l

—

Urticaria

194

1578

1.23

2.14

1.4

8.03

7.89

mmol/l

0.21

186

1521

Behavioural syndromes associated with physiological disturbances and physical factors

617

3712

1.13

2.13

1.4

8.74

8.23

mmol/l

1.97

596

3549

Other viral diseases, including avohilmo

273

2276

1.19

2.11

1.5

1.4

7.76

7.82

mmol/l

0.10

264

2201

Triptan medication for migraine, min. 3 purchases

434

2824

1.15

2.11

1.5

7.42

7.63

mmol/l

0.58

426

2739

Other and unspecified tonsillitis

271

1892

1.19

2.11

1.5

8.17

7.70

mmol/l

1.06

262

1834

Non-ischemic cardiomyopathy

115

695

1.31

2.10

1.2

1.3

10.57

9.04

mmol/l

2.65

107

652

Disorders of synovium and tendon

322

2332

1.17

2.07

1.3

1.4

8.05

8.45

mmol/l

1.07

307

2223

Bleeding

414

2521

1.15

2.07

1.3

9.76

8.98

mmol/l

2.70

380

2377

Injuries to the abdomen, lower back, lumbar spine and pelvis

226

1848

1.21

2.06

1.3

1.4

9.15

8.42

mmol/l

1.74

214

1759

Cervicobrachial syndrome

117

901

1.30

2.06

1.3

8.39

8.67

mmol/l

0.29

112

847

Convulsions, not elsewhere classified

137

1064

1.27

2.05

1.4

9.45

8.05

mmol/l

2.64

131

1008

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

527

2940

1.13

2.04

1.3

9.36

8.75

mmol/l

2.12

503

2773

Other hearing loss

118

882

1.30

2.03

1.3

9.60

9.18

mmol/l

0.57

110

831

Other disorders of white blood cells

155

1.75

2.00

1.4

9.51

9.02

mmol/l

0.28

150

Gastric ulcer

467

1.42

2.00

1.2

1.3

10.26

9.00

mmol/l

1.21

438

Additional codes for the location of defect, injury or illness

201

1.65

1.99

1.3

1.4

8.04

8.91

mmol/l

0.71

194

Any mental disorder

693

3114

1.12

1.98

1.3

1.4

9.13

8.13

mmol/l

6.80

660

2971

ILD medications

756

3675

1.11

1.98

1.3

1.4

8.81

8.11

mmol/l

4.23

714

3532

Recurrent or chronic depression

267

1561

1.19

1.98

1.4

9.42

7.78

mmol/l

5.58

259

1502

Hypothyroidism, strict autoimmune, 3 medication purchases required

556

3322

1.13

1.95

1.4

8.55

8.00

mmol/l

2.48

526

3193

Conduction disorders

124

774

1.29

1.95

1.2

1.3

9.15

9.19

mmol/l

0.03

117

728

Venous thromboembolism

245

1983

1.19

1.95

1.3

9.84

9.16

mmol/l

1.29

229

1858

Complications of medical and surgical care

414

3256

1.14

1.94

1.3

9.04

8.55

mmol/l

1.31

395

3094

Other arrhythmias

360

2326

1.16

1.94

1.3

1.4

8.78

8.44

mmol/l

0.79

345

2207

Certain disorders involving the immune mechanism

666

1.34

1.94

1.4

1.3

9.07

9.06

mmol/l

0.01

631

Diseases of salivary glands

182

1490

1.22

1.93

1.3

1.4

8.51

8.38

mmol/l

0.17

173

1419

Oxycodone

170

1183

1.23

1.87

1.1

1.2

10.06

9.29

mmol/l

1.19

158

1122

Haemorrhage from respiratory passages

156

1116

1.24

1.85

1.2

1.3

10.14

9.18

mmol/l

1.66

142

1054

Seborrhoeic keratosis

105

812

1.30

1.83

1.2

8.92

9.10

mmol/l

0.17

762

Other and unspecified local infections of skin and subcutaneous tissue

318

1.48

1.83

1.2

1.4

10.79

8.86

mmol/l

1.51

304

Intestinal stricture

132

1052

1.26

1.81

1.2

1.3

9.49

9.19

mmol/l

0.30

125

981

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

177

1457

1.22

1.80

1.4

9.27

8.44

mmol/l

1.27

171

1385

Codeine or tramadol medication

738

3633

1.10

1.80

1.3

1.4

9.22

8.09

mmol/l

8.27

684

3499

Meniscus derangement

272

1537

1.18

1.80

1.2

1.3

9.09

9.32

mmol/l

0.32

252

1442

Gonarthrosis,primary

401

2117

1.14

1.80

1.2

9.00

9.63

mmol/l

2.05

376

1970

Salpingitis and oophoritis

606

1.34

1.79

1.3

1.4

7.83

8.43

mmol/l

0.81

583

Other obstetric trauma

296

1.50

1.77

1.6

1.5

6.73

7.35

mmol/l

0.88

289

Polyarthropathies

398

2242

1.14

1.77

1.3

1.4

9.34

8.50

mmol/l

3.12

375

2135

Retention of urine

148

967

1.24

1.76

1.2

1.3

9.88

9.24

mmol/l

0.88

138

899

Superficial injury of shoulder and upper arm

446

1.39

1.75

1.3

1.4

7.90

8.58

mmol/l

0.75

428

Exposure to unspecified factor

547

4141

0.90

1.74

1.3

1.4

9.46

8.19

mmol/l

7.81

510

3977

Injuries to the wrist and hand

662

3970

1.11

1.74

1.3

1.4

8.58

8.27

mmol/l

0.95

630

3802

Spondylopathies

391

2026

1.14

1.74

1.3

9.08

9.01

mmol/l

0.11

368

1907

Benign thyroid growths and nodules

143

1074

1.24

1.73

1.3

9.12

8.80

mmol/l

0.35

137

1018

Concussion

318

2137

1.15

1.73

1.4

8.41

7.87

mmol/l

1.47

303

2066

Coxarthrosis

223

1210

1.19

1.72

1.2

9.27

9.65

mmol/l

0.62

206

1124

Acute appendicitis, no complications

344

2988

1.15

1.72

1.4

8.46

8.31

mmol/l

0.27

334

2844

Ill-defined and unknown causes of mortality

243

0.49

1.71

1.0

1.2

13.93

9.59

mmol/l

1.66

227

Gingival hyperplasia

118

1.79

1.70

1.3

1.5

8.65

8.56

mmol/l

0.05

112

Primary gonarthrosis, bilateral

217

1531

1.19

1.70

1.3

1.2

8.74

9.74

mmol/l

2.81

203

1420

Subjective visual disturbances

133

1071

1.24

1.69

1.3

1.4

8.19

8.47

mmol/l

0.43

128

1034

Congenital malformations, deformations and chromosomal abnormalities

395

3306

1.13

1.68

1.4

7.97

7.99

mmol/l

0.04

383

3178

Melanocytic naevi

189

1579

1.20

1.68

1.4

7.91

8.07

mmol/l

0.22

179

1515

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

631

3606

1.11

1.67

1.3

1.4

8.84

8.22

mmol/l

3.34

601

3460

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

433

3504

1.13

1.67

1.4

8.08

8.05

mmol/l

0.06

421

3356

COPD

182

1228

1.20

1.66

1.2

9.96

9.59

mmol/l

0.48

160

1145

Other retinal disorders

296

1945

1.16

1.66

1.2

1.3

10.67

9.04

mmol/l

7.06

270

1830

Atopic dermatitis

422

2980

1.13

1.65

1.5

1.4

8.15

7.91

mmol/l

0.57

407

2873

Other chronic obstructive pulmonary disease

173

1172

1.21

1.65

1.2

10.05

9.63

mmol/l

0.53

152

1092

Other diseases of pericardium

112

1.79

1.64

1.3

7.98

9.51

mmol/l

0.99

107

Gonarthrosis [arthrosis of knee](FG)

351

1765

1.14

1.64

1.3

1.2

8.85

9.46

mmol/l

1.70

329

1649

Nonischemic cardiomyopathy

228

1.54

1.64

1.4

1.2

10.36

9.58

mmol/l

0.39

214

Other local infections of skin and subcutaneous tissue

343

1.43

1.63

1.3

1.4

10.67

8.98

mmol/l

1.31

327

Deforming dorsopathies

150

1229

1.22

1.63

1.4

8.39

8.51

mmol/l

0.14

141

1162

Urticaria and erythema

227

1933

1.18

1.63

1.4

8.20

7.95

mmol/l

0.45

218

1857

Other vitreous opacities

130

0.38

1.62

2.4

1.4

8.54

8.90

mmol/l

—

123

Glaucoma-related operations

130

0.38

1.62

1.2

11.52

9.50

mmol/l

—

122

Lateral epicondylitis

454

1.37

1.60

1.3

8.82

8.89

mmol/l

0.04

428

Heterophoria

353

1.42

1.60

1.6

1.5

7.53

7.92

mmol/l

0.34

342

Paralytic ileus and intestinal obstruction

106

837

1.27

1.60

1.2

1.3

9.56

9.02

mmol/l

0.55

101

775

Dizziness and giddiness

417

2881

1.13

1.59

1.4

8.62

8.55

mmol/l

0.13

392

2742

Suppurative and unspecified otitis media

276

2116

1.16

1.59

1.6

1.5

7.72

7.63

mmol/l

0.14

263

2064

Inflammatory diseases of female pelvic organs

455

2779

1.12

1.58

1.4

1.5

7.61

7.53

mmol/l

0.19

433

2715

Cervical disc disorders

161

1335

1.21

1.57

1.2

8.95

9.40

mmol/l

0.61

146

1237

Conjunctivitis (acute, non atopic)

175

1457

1.20

1.56

1.3

1.4

8.63

8.02

mmol/l

1.25

167

1402

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.86

1.56

1.2

9.74

9.94

mmol/l

0.07

Other ill-defined and unspecified causes of mortality

221

0.50

1.55

1.0

1.2

13.98

9.68

mmol/l

1.44

209

Collagenous colitis

297

1.45

1.55

1.3

1.4

9.34

8.80

mmol/l

0.30

283

Ectopic pregnancy

102

807

1.27

1.54

1.5

1.4

7.19

7.68

mmol/l

0.83

776

Noninflammatory disorders of female genital tract

325

1424

1.15

1.54

1.6

1.5

7.31

7.22

mmol/l

0.19

317

1395

Medical abortion

436

2102

1.12

1.53

1.5

1.4

7.86

7.56

mmol/l

0.84

420

2045

Spondylolisthesis/Spondylolysis

640

1.30

1.53

1.3

9.00

9.11

mmol/l

0.08

598

Constipation

480

2917

1.12

1.53

1.3

9.37

8.71

mmol/l

2.58

452

2760

Certain infectious and parasitic diseases, including avohilmo

449

2006

1.12

1.53

1.4

8.92

7.91

mmol/l

5.05

427

1944

Appendicitis, broad definition

452

3635

1.12

1.52

1.4

8.59

8.37

mmol/l

0.54

435

3464

Sleep disorders

586

3662

1.10

1.51

1.3

1.4

8.66

8.20

mmol/l

1.62

566

3503

Plantar fascial fibromatosis

316

1.43

1.50

1.3

8.73

8.65

mmol/l

0.05

304

Diseases of the eye and adnexa

576

2614

1.10

1.48

1.4

8.30

7.99

mmol/l

0.98

548

2529

Early onset COPD

732

1.27

1.48

1.2

10.13

9.31

mmol/l

0.96

682

Certain infectious and parasitic diseases

636

2901

1.10

1.47

1.4

9.05

7.89

mmol/l

7.62

598

2812

Other bursitis of knee

2.39

1.46

1.4

5.92

9.08

mmol/l

—

ILD medications: prednisolone, methylprednisolone, prednisone

706

3594

1.09

1.46

1.3

1.4

8.84

8.14

mmol/l

3.98

667

3451

Contact with and exposure to communicable diseases

245

2112

1.16

1.46

1.4

1.5

6.70

7.40

mmol/l

3.58

239

2070

Pneumonitis due to solids and liquids

211

1.52

1.45

1.2

1.3

10.65

9.44

mmol/l

0.78

200

Acute suppurative otitis media

211

1683

1.17

1.45

1.5

7.88

7.44

mmol/l

0.80

201

1647

Trigger finger

506

1.33

1.45

1.1

1.3

9.26

8.76

mmol/l

0.42

474

Diseases of appendix

453

3642

1.11

1.45

1.4

8.58

8.37

mmol/l

0.48

436

3470

Type 1 diabetes, wide definition, subgroup 2

3.14

1.44

2.2

1.4

6.72

8.11

mmol/l

—

Other specified/unspecified systemic involvement of connective tissue

180

1.56

1.43

1.3

1.5

10.14

8.75

mmol/l

0.44

173

Fracture of rib(s), sternum and thoracic spine

133

1095

1.22

1.42

1.2

1.3

9.67

9.30

mmol/l

0.34

124

1027

Exclusions for E4_PCOS_CONSORTIUM

404

2815

0.89

1.41

1.4

8.72

7.74

mmol/l

3.85

376

2738

Malignant melanoma

491

1.33

1.41

1.3

9.50

9.06

mmol/l

0.32

464

Benign neoplasm: Skin of eyelid, including canthus

474

1.33

1.41

1.2

1.3

8.35

9.01

mmol/l

0.65

453

Other and unspecified disorders of skin and subcutaneous tissue

178

0.50

1.39

1.2

1.4

7.82

8.85

mmol/l

—

169

Other diseases of lip and oral mucosa

218

1879

1.16

1.39

1.3

8.83

8.55

mmol/l

0.42

210

1768

D07AA Corticosteroids, weak (group I)

773

1.26

1.39

1.5

8.14

7.78

mmol/l

0.39

754

Fracture of lower leg, including ankle

291

2512

1.14

1.39

1.3

9.39

8.69

mmol/l

1.93

275

2377

Overexertion and strenuous or repetitive movements

355

1.38

1.39

1.3

1.4

9.85

8.69

mmol/l

0.93

338

Other medical care

213

1535

1.17

1.39

1.2

1.3

10.48

8.85

mmol/l

4.13

201

1443

Other neurotic disorders

119

1.69

1.37

1.5

1.4

9.55

9.34

mmol/l

0.07

113

Monoamine oxidase A inhibitors

373

1.37

1.2

1.3

9.19

8.79

mmol/l

0.19

356

Use of pramipexole

678

1.27

1.37

1.2

1.3

9.68

9.32

mmol/l

0.23

639

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

182

1.54

1.37

1.1

1.3

9.00

9.30

mmol/l

0.14

176

Congenital malformations of eye, ear, face and neck

306

1.41

1.36

1.5

7.39

7.70

mmol/l

0.27

301

Hyperplasia of prostate

149

697

1.21

1.36

1.2

9.79

10.37

mmol/l

0.77

142

631

Aortic valve malfunction, age under 60 years

298

1.41

1.35

1.4

1.3

8.66

9.24

mmol/l

0.53

283

Ingrowing nail

183

1.54

1.34

1.1

1.4

9.39

8.74

mmol/l

0.35

177

Malignant melanoma of skin

366

1.37

1.34

1.3

10.15

9.24

mmol/l

0.62

347

Glaucoma

233

1717

1.15

1.34

1.3

1.2

9.16

9.41

mmol/l

0.42

216

1604

Acetic acid derivatives and related substances

167

725

1.19

1.34

1.3

1.5

8.66

7.97

mmol/l

1.42

160

703

Ptosis of eyelid

307

1.40

1.33

1.4

1.3

10.71

9.43

mmol/l

0.80

286

Otitis externa

121

996

1.22

1.32

1.3

1.4

8.97

8.35

mmol/l

0.82

112

957

Urinary track infection

442

1993

1.11

1.32

1.4

1.5

8.00

7.25

mmol/l

3.61

426

1947

Complications of anaesthesia during the puerperium

2.57

1.32

2.0

1.5

9.08

7.63

mmol/l

—

Other intervertebral disc disorders

474

2557

1.11

1.31

1.3

1.4

8.84

8.52

mmol/l

0.86

453

2433

Malignant neoplasm of brain, including Hilmo

150

0.46

1.31

1.0

1.3

10.21

8.95

mmol/l

—

142

COPD, hospital admissions

176

1262

1.18

1.30

1.2

10.14

9.48

mmol/l

1.04

155

1178

Benign neoplasm: Pineal gland

2.88

1.30

1.0

1.6

8.10

6.77

mmol/l

—

Dentofacial anomalies [including malocclusion]

473

3357

1.10

1.30

1.5

1.4

7.36

8.13

mmol/l

5.80

463

3219

Other noninflammatory disorders of uterus, except cervix

465

1.26

1.29

1.4

1.3

8.94

8.85

mmol/l

0.06

443

Thyrotoxicosis with toxic multinodular goitre

145

1.59

1.29

1.1

1.3

9.86

9.18

mmol/l

0.27

136

Polyp of the female genital tract

114

787

0.82

1.29

1.5

1.4

8.51

7.94

mmol/l

0.86

107

760

Coxarthrosis [arthrosis of hip](FG)

235

1407

1.15

1.28

1.2

9.37

9.67

mmol/l

0.46

217

1307

Other chronic obstructive pulmonary disease, including avohilmo

218

1552

1.15

1.28

1.2

10.18

9.57

mmol/l

1.05

194

1448

Glucosamine medication

168

1139

1.18

1.27

1.1

1.2

9.07

9.53

mmol/l

0.81

155

1060

Persons encountering health services for examination and investigation

389

1749

1.12

1.27

1.4

9.04

7.94

mmol/l

4.94

369

1668

Malignant melanoma of skin, including Hilmo

457

1.32

1.26

1.3

9.77

9.12

mmol/l

0.48

433

Later onset COPD, excluding more controls

447

1.28

1.25

1.2

10.03

9.76

mmol/l

0.17

426

Menorrhagia

228

1106

1.15

1.23

1.4

1.5

7.31

7.46

mmol/l

0.30

218

1078

Viral warts, including avohilmo

137

1152

1.19

1.22

1.4

7.75

8.04

mmol/l

0.44

131

1110

Malignant neoplasm of prostate

574

0.79

1.20

1.2

9.10

10.00

mmol/l

1.38

532

Left ventricular outflow tract obstruction (LVOTO), broad definition

331

1.36

1.20

1.4

1.3

8.59

9.15

mmol/l

0.53

314

COPD, early/later onset

177

1276

1.16

1.20

1.2

10.06

9.48

mmol/l

0.86

156

1188

Myocardial infarction, unclassifiable

466

1.29

1.19

1.3

1.2

9.70

9.81

mmol/l

0.08

433

Systemic connective tissue disorders

159

1359

1.17

1.18

1.2

1.3

9.12

8.51

mmol/l

0.77

153

1289

Insomnia

577

3693

1.09

1.18

1.4

8.63

8.17

mmol/l

1.59

557

3533

Nasal polyp

676

1.24

1.17

1.3

9.34

9.36

mmol/l

0.01

634

Basal cell carcinoma

135

1090

0.84

1.17

1.2

9.87

9.32

mmol/l

0.68

120

1022

Gonarthrosis

293

1470

1.13

1.17

1.3

1.2

8.81

9.41

mmol/l

1.46

273

1375

Other viral diseases

183

1578

1.16

1.5

1.4

7.92

7.97

mmol/l

0.06

175

1520

Intracranial trauma

359

2183

1.11

1.16

1.4

8.60

7.85

mmol/l

2.64

340

2112

Other inflammation of eyelid

508

1.28

1.15

1.3

8.62

8.85

mmol/l

0.19

485

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

210

0.57

1.14

1.0

1.3

10.25

8.82

mmol/l

0.50

200

Injuries to the knee and lower leg

764

3842

1.07

1.14

1.3

1.4

8.64

8.23

mmol/l

1.77

730

3677

Varicose veins of other sites

150

1.54

1.14

1.2

1.3

10.69

9.83

mmol/l

0.32

139

Diseases of the musculoskeletal system and connective tissue

395

1791

1.11

1.13

1.5

8.20

7.85

mmol/l

0.93

383

1729

Nontoxic goitre/thyroid nodule

117

978

1.20

1.13

1.3

9.17

8.77

mmol/l

0.39

111

929

Other congenital malformations of ear

1.72

1.12

2.0

1.6

6.19

7.04

mmol/l

1.23

Acute appendicitis

417

3525

1.10

1.12

1.4

8.60

8.37

mmol/l

0.54

403

3362

Autoimmune diseases related-to ILD

517

3969

1.09

1.11

1.4

9.02

8.27

mmol/l

3.15

486

3803

Cough

209

1709

1.14

1.11

1.3

1.4

9.03

8.45

mmol/l

1.03

200

1631

Benign neoplasm: Small intestine

1.71

1.11

1.4

1.3

10.95

9.92

mmol/l

0.52

Vascular syndromes of brain in cerebrovascular disorders

1.67

1.10

1.2

10.51

9.04

mmol/l

0.67

Operations 2 for CAVS

787

1.21

1.09

1.2

9.23

9.81

mmol/l

0.74

730

Calcific aortic valvular stenosis, diagnosis (helper)

787

1.21

1.09

1.2

9.23

9.81

mmol/l

0.74

730

Other viral diseases, not elsewhere classified

780

1.22

1.08

1.5

1.4

8.32

8.35

mmol/l

0.02

752

Prominent ears

1.78

1.08

1.9

1.7

5.98

6.99

mmol/l

1.45

Other external causes of accidental injury

545

2514

1.09

1.07

1.4

8.57

8.01

mmol/l

2.12

523

2421

Calcific aortic valvular stenosis, operated

789

1.21

1.07

1.2

9.23

9.80

mmol/l

0.72

732

Calcific aortic valvular stenosis

789

1.21

1.07

1.2

9.23

9.80

mmol/l

0.72

732

Depression or dysthymia

388

1923

1.10

1.06

1.3

1.4

9.55

8.19

mmol/l

6.31

374

1839

Polypectomy (DHB20)

194

1.45

1.06

1.2

1.3

10.11

9.37

mmol/l

0.36

188

malignant neoplasm of male genital organs

600

0.81

1.06

1.1

1.2

9.25

10.06

mmol/l

1.17

557

Calcific aortic valvular stenosis, including rheumatic fever

790

1.21

1.04

1.2

9.23

9.82

mmol/l

0.76

733

Other malignant neoplasms of skin (=non-melanoma skin cancer)

142

1123

0.86

1.04

1.2

9.91

9.31

mmol/l

0.86

127

1052

Enterobiasis, including avohilmo

146

1.52

1.04

1.3

1.5

7.90

7.39

mmol/l

0.27

146

Benzodiazepine use

629

3944

1.08

1.03

1.3

1.4

9.40

8.20

mmol/l

7.85

595

3777

Postprocedural disorders of nervous system

332

1.33

1.03

1.4

1.5

7.35

7.85

mmol/l

0.32

325

Medical observation and evaluation for suspected diseases and conditions

377

1749

1.10

1.03

1.4

9.00

7.94

mmol/l

4.71

361

1668

Other benign neoplasms of skin

165

1435

1.15

1.02

1.2

1.3

8.51

8.81

mmol/l

0.46

155

1353

Dermatitis

353

3140

1.10

1.01

1.3

1.4

8.57

8.42

mmol/l

0.29

332

2996

Injuries to the thorax

217

1921

1.13

1.01

1.3

9.69

8.91

mmol/l

1.43

202

1806

Other and unspecified disorders of white blood cells

115

1.57

0.99

1.6

1.3

9.14

8.84

mmol/l

0.16

110

Fracture of foot, except ankle

138

1187

1.16

0.99

1.4

7.86

8.11

mmol/l

0.29

133

1145

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.99

0.0

1.4

—

7.65

—

Melanocytic naevi of other and unspecified parts of face

223

1.39

0.98

1.4

7.71

8.36

mmol/l

0.38

215

Coxibs

162

736

1.16

0.97

1.4

8.77

7.94

mmol/l

1.60

155

714

Malignant neoplasm of ovary, including Hilmo

187

0.59

0.97

1.5

1.3

7.46

8.10

mmol/l

0.30

179

Other mental disorders due to brain damage and dysfunction and to physical disease

292

1.34

0.97

1.2

1.3

9.41

9.47

mmol/l

0.03

277

Accidents

542

2514

1.08

0.96

1.4

8.56

8.01

mmol/l

2.07

520

2421

Malignant neoplasm, wide definition

400

2539

0.92

0.96

1.2

1.3

9.73

8.61

mmol/l

4.54

368

2420

Diseases of peritoneum

293

1.33

0.95

1.4

9.57

9.20

mmol/l

0.18

280

Impingement syndrome of shoulder

804

1.20

0.95

1.2

8.74

9.51

mmol/l

0.99

737

Malignant melanoma, including Hilmo

568

1.23

0.95

1.3

9.46

8.91

mmol/l

0.45

535

Speech disturbances, not elsewhere classified

242

1.37

0.94

1.2

1.3

9.49

9.34

mmol/l

0.07

230

Benign neoplasm: Rectum, anus and anal canal

605

1.22

0.94

1.3

1.2

11.44

9.41

mmol/l

2.37

564

Special screening examination for infectious and parasitic diseases

137

1155

0.86

0.94

1.3

1.5

9.07

7.36

mmol/l

4.53

132

1119

Primary_lymphoid and hematopoietic malignant neoplasms

760

1.20

0.94

1.2

1.3

9.14

9.15

mmol/l

0.01

715

Primary coxarthrosis, bilateral

102

861

1.19

0.93

1.2

9.25

9.56

mmol/l

0.27

803

Unspecified fall

266

2355

1.11

0.93

1.3

1.4

8.94

8.54

mmol/l

0.75

250

2237

Asthma and allergy

733

1.20

0.93

1.4

1.5

8.29

7.32

mmol/l

1.54

719

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

206

1598

1.13

0.91

1.5

1.6

7.72

6.98

mmol/l

2.18

199

1581

Diseases of the respiratory system

386

1771

1.09

0.91

1.4

8.51

8.18

mmol/l

0.79

369

1709

Non-invasive ventilation

681

1.19

0.90

1.3

1.5

8.03

6.35

mmol/l

4.53

674

Injury of muscle and tendon at shoulder and upper arm level

151

1320

1.15

0.90

1.1

1.2

9.27

9.59

mmol/l

0.31

143

1220

Other congenital malformations of the digestive system, including avohilmo

175

1.42

0.89

1.3

1.5

9.09

7.99

mmol/l

0.72

170

severe traumatic brain injury, does not include concussion

700

1.20

0.89

1.3

1.2

10.11

9.33

mmol/l

0.86

654

Benign neoplasm of other and unspecified female genital organs

135

1.49

0.89

1.5

1.4

7.06

8.46

mmol/l

1.09

128

Propionic acid derivatives

169

747

1.14

0.86

1.4

8.43

7.97

mmol/l

0.73

161

724

Asthma and allergy, excluding more controls

740

1.19

0.86

1.4

1.5

8.29

7.29

mmol/l

1.61

726

Diabetic maculopathy

880

0.83

0.85

1.2

1.3

12.90

10.89

mmol/l

2.60

797

Asthma/COPD (KELA code 203)

598

3741

1.07

0.85

1.3

1.4

8.55

8.24

mmol/l

1.04

567

3594

Fibroblastic disorders

797

1.18

0.84

1.3

1.2

9.33

9.22

mmol/l

0.11

738

Vascular dementia (subcortical)

1.76

0.83

1.3

1.1

8.90

9.77

mmol/l

—

Other diseases of the respiratory system

569

1.21

0.83

1.2

1.3

10.13

9.33

mmol/l

0.72

533

Other respiratory disorders and diseases

569

1.21

0.83

1.2

1.3

10.13

9.33

mmol/l

0.72

533

Pacemaker

125

1008

1.15

0.83

1.1

1.2

9.56

9.54

mmol/l

0.02

118

938

Other congenital malformations of skin, including avohilmo

327

1.29

0.83

1.5

1.4

8.03

8.17

mmol/l

0.10

319

Neoplasms

566

2775

1.07

0.83

1.4

1.5

8.44

7.83

mmol/l

2.67

546

2687

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

307

2755

1.09

0.82

1.4

1.3

8.89

8.65

mmol/l

0.42

294

2602

Solid cancers

369

2346

0.92

0.82

1.2

1.3

9.79

8.74

mmol/l

3.76

343

2229

Fever of other and unknown origin

312

2476

1.09

0.81

1.4

9.05

8.23

mmol/l

2.63

295

2358

Other and unspecified injuries of neck

1.72

0.81

1.3

1.7

5.57

7.38

mmol/l

—

Malignant neoplasm

384

2433

0.92

0.81

1.2

1.3

9.73

8.69

mmol/l

3.89

356

2314

Other disorders of eyelid

173

1451

1.13

0.81

1.3

1.2

9.56

9.23

mmol/l

0.40

168

1349

Vasomotor and allergic rhinitis

241

2134

1.10

0.81

1.4

7.86

7.93

mmol/l

0.11

228

2058

Unicornuate uterus

0.00

0.80

0.0

1.6

—

7.10

—

Atopic dermatitis, strict definition with reimbursement

225

1955

1.11

0.79

1.5

8.28

7.40

mmol/l

2.67

218

1911

Osteopathies and chondropathies

273

2277

1.10

0.79

1.3

9.70

8.69

mmol/l

2.73

259

2146

Other bursitis, not elsewhere classified

0.00

0.78

0.0

1.2

—

9.62

—

Malignant neoplasm of breast, HER-positive

102

882

0.86

0.78

1.2

1.3

8.74

8.73

mmol/l

0.01

837

Ovarian hyperstimulation (induction)

123

1.48

0.78

1.2

1.6

6.57

7.15

mmol/l

0.70

123

Other condition

547

1.21

0.77

1.3

1.4

7.48

8.70

mmol/l

2.06

528

Epilepsy

134

1174

1.14

0.77

1.3

1.4

8.15

8.48

mmol/l

0.47

128

1107

5-aminosalicylic acid

111

963

1.15

0.77

1.4

8.10

8.27

mmol/l

0.18

106

918

ILD medications: immunosuppressive drugs

367

3076

1.08

0.77

1.3

1.4

9.31

8.36

mmol/l

3.39

347

2939

Benign neoplasm: Rectum

530

1.21

0.76

1.3

1.2

11.43

9.39

mmol/l

2.23

497

Malignant neoplasm, including Hilmo

405

2537

0.93

0.75

1.2

1.3

9.71

8.61

mmol/l

4.50

374

2418

Lesion of plantar nerve

149

1.41

0.75

1.1

1.2

8.64

9.55

mmol/l

0.68

140

Complications of anaesthesia during labour and delivery

2.12

0.75

2.0

1.7

7.72

7.81

mmol/l

—

Bacterial pneumonia (organism specified)

195

1590

1.11

0.74

1.3

9.90

8.78

mmol/l

2.50

182

1500

Oter anti-inflammatory and antirheumatic agents, non-steroids

390

1.18

0.74

1.2

9.31

9.32

mmol/l

0.01

368

Noninfective enteritis and colitis

250

2279

1.10

0.74

1.3

1.4

8.64

8.36

mmol/l

0.47

241

2163

Inguinal hernia

224

1640

0.91

0.74

1.2

1.3

8.83

9.43

mmol/l

1.06

203

1547

Diseases of external ear

171

1531

1.12

0.74

1.3

9.10

8.59

mmol/l

0.83

158

1447

Psychiatric diseases

589

2774

1.06

0.74

1.3

1.4

9.14

8.12

mmol/l

6.32

562

2644

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

283

2592

1.09

0.74

1.4

1.3

8.85

8.71

mmol/l

0.20

270

2450

Injuries to the hip and thigh

218

1772

1.10

0.73

1.2

1.3

9.12

8.94

mmol/l

0.24

209

1670

Cardiodefibrillation

125

1095

1.14

0.73

1.2

9.50

9.81

mmol/l

0.32

114

1009

Malignant neoplasm of breast, ER-positive, including Hilmo

103

883

0.87

0.73

1.2

1.3

8.74

8.75

mmol/l

0.00

838

Carcinoma in situ of cervix uteri

776

0.84

0.73

1.5

1.6

6.49

7.02

mmol/l

1.31

759

Falls/tendency to fall

709

3359

1.06

0.73

1.4

8.78

8.07

mmol/l

3.77

675

3228

Contact with hypodermic needle

1.82

0.73

1.4

1.6

5.49

7.13

mmol/l

—

Other congenital malformations of the digestive system

149

1.40

0.73

1.4

1.5

9.01

7.92

mmol/l

0.58

144

Arthropathies

627

2987

1.06

0.73

1.4

8.05

8.07

mmol/l

0.05

601

2877

Other joint disorders

607

2982

1.06

0.72

1.4

7.75

8.08

mmol/l

1.21

582

2872

Other specific joint derangements/joint disorders

506

2956

1.07

0.72

1.4

8.17

8.08

mmol/l

0.21

484

2846

Cysts of oral region, not elsewhere classified

195

0.66

0.72

1.4

9.40

8.88

mmol/l

0.18

188

Carcinoma in situ of skin of trunk

1.67

0.72

1.2

9.65

9.96

mmol/l

—

Basal cell carcinoma, including Hilmo

151

1148

0.89

0.72

1.2

9.80

9.30

mmol/l

0.63

133

1076

Spondyloarthritis

681

1.18

0.72

1.4

1.3

8.45

8.55

mmol/l

0.08

653

Alzheimer disease, including avohilmo

709

0.86

0.71

1.1

1.2

9.52

9.77

mmol/l

0.22

664

Malignant neoplasm of prostate, including Hilmo

586

0.85

0.71

1.2

9.10

10.00

mmol/l

1.43

544

Use of anticholinesterases

739

0.85

0.71

1.1

1.2

10.11

9.77

mmol/l

0.26

689

N06DA Anticholinesterases

739

0.85

0.71

1.1

1.2

10.11

9.77

mmol/l

0.26

689

Malignant neoplasm

387

2434

0.93

0.71

1.2

1.3

9.73

8.69

mmol/l

3.89

359

2315

Intracranial injury

332

2866

1.08

0.70

1.4

8.67

8.32

mmol/l

0.79

316

2735

IBD patients in KELA-register

123

1085

1.14

0.69

1.4

8.23

8.30

mmol/l

0.06

118

1038

Internal derangement of knee

196

1758

1.10

0.69

1.3

8.37

8.66

mmol/l

0.46

186

1665

Diaphragmatic hernia

140

1245

1.13

0.69

1.2

9.79

9.31

mmol/l

0.59

130

1170

Acute peritonitis

169

1.36

0.69

1.3

10.65

9.58

mmol/l

0.42

160

Other diseases of peritoneum

118

1.44

0.69

1.5

1.4

7.86

8.83

mmol/l

0.53

113

COPD, hospital admission 2, with asthma infections

114

861

1.14

0.68

1.2

9.98

9.40

mmol/l

0.62

102

805

Conductive and sensorineural hearing loss

363

2240

1.08

0.68

1.3

9.05

9.20

mmol/l

0.28

335

2107

Solid cancers, including Hilmo

394

2458

0.93

0.67

1.2

1.3

9.83

8.67

mmol/l

4.62

363

2339

Allergic rhinitis

204

1833

1.10

0.67

1.4

1.5

7.77

7.69

mmol/l

0.12

196

1786

Amiodarone users

249

1.29

0.67

1.1

1.2

11.70

10.26

mmol/l

0.57

233

Ulcerative colitis

125

1108

1.13

0.66

1.4

8.17

8.38

mmol/l

0.24

120

1058

Hypermobility syndrome

285

1.27

0.66

1.4

1.5

7.28

7.47

mmol/l

0.11

280

Myeloproliferative diseases (CML excluded)

188

1.33

0.66

1.4

1.3

9.63

9.76

mmol/l

0.05

179

Herpesviral keratitis and keratoconjunctivitis

128

1.41

0.65

1.4

8.94

9.00

mmol/l

0.02

123

Spinal stenosis

196

1312

1.10

0.65

1.2

10.01

9.71

mmol/l

0.41

183

1215

Glaucoma secondary to other eye disorders

103

1.46

0.65

1.5

1.3

7.89

9.11

mmol/l

0.58

Inflammatory bowel disease, strict (require KELA)

123

1092

1.13

0.64

1.4

8.23

8.30

mmol/l

0.06

118

1046

Artrosis, including avohilmo

421

2158

1.07

0.64

1.3

8.85

8.93

mmol/l

0.13

393

2041

Fracture of lumbar spine and pelvis

706

1.16

0.64

1.3

9.97

8.97

mmol/l

1.07

673

Fall on same level involving ice and snow

307

2851

1.08

0.63

1.3

8.75

8.56

mmol/l

0.33

291

2705

Zoster [herpes zoster], including avohilmo

243

2159

1.09

0.63

1.3

9.29

8.77

mmol/l

1.00

234

2036

Benign neoplasm: Ascending colon

396

1.21

0.62

1.2

10.90

9.65

mmol/l

1.03

368

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

174

1579

1.10

0.62

1.3

1.4

8.32

8.08

mmol/l

0.32

166

1521

Benign neoplasm: Skin of ear and external auricular canal

105

0.57

0.61

1.2

1.4

12.72

9.02

mmol/l

—

100

Sulfasalazine

139

1248

1.11

0.61

1.5

1.4

8.54

8.42

mmol/l

0.12

130

1181

Use of hypnotics and sedatives

597

3235

1.05

0.61

1.3

1.4

9.48

8.48

mmol/l

5.09

554

3087

Brain astrocytoma, helper endpoint

0.00

0.61

0.0

1.5

—

8.68

—

Convalescence

165

1.34

0.60

1.2

1.5

8.05

8.55

mmol/l

0.26

159

Coxarthrosis, primary

229

1749

1.09

0.60

1.2

9.33

9.63

mmol/l

0.43

211

1626

Assault by hanging, strangulation and suffocation

0.00

0.60

0.0

1.5

—

7.64

—

Neovascular glaucoma

105

1.43

0.60

1.5

1.3

7.89

9.10

mmol/l

0.58

100

Palatinal maxillary canine

1.55

0.60

1.1

1.7

8.59

6.91

mmol/l

—

Leiomyoma of uterus

251

1523

0.92

0.59

1.4

1.3

8.73

8.35

mmol/l

0.67

233

1461

Pleural plaque with presence of asbestos

174

0.69

0.59

1.1

1.2

8.42

10.38

mmol/l

1.58

161

Liquid cancers, including Hilmo

143

1136

1.11

0.58

1.2

9.21

9.17

mmol/l

0.04

134

1070

Inflammatory disorders of male genital organs, not elsewhere classified

0.00

0.58

0.0

1.1

—

10.87

—

Reimbursement for rheumatic diseases

242

2596

0.93

0.58

1.4

1.3

9.22

8.54

mmol/l

1.41

227

2463

Liquid cancers

115

971

1.12

0.57

1.2

1.3

9.21

9.10

mmol/l

0.10

106

918

Disorders of eyelid, lacrimal system and orbit

476

3299

1.06

0.57

1.3

8.70

8.54

mmol/l

0.33

458

3130

Mixed specific developmental disorders

0.56

1.0

1.6

8.90

7.42

mmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.54

0.55

1.6

1.1

7.48

9.46

mmol/l

—

Later onset COPD

598

1.14

0.55

1.2

10.05

9.77

mmol/l

0.20

559

Progressive vascular leukoencephalopathy

1.54

0.55

1.1

11.92

10.01

mmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

679

1.14

0.55

1.2

9.93

9.58

mmol/l

0.28

635

Unspecific neurodegenerative disorder

109

834

0.89

0.53

1.2

9.81

9.68

mmol/l

0.10

102

779

Superficial injury of thorax

562

1.16

0.53

1.3

1.4

9.70

8.72

mmol/l

0.90

537

Arthrosis

341

1753

1.07

0.53

1.3

8.93

9.09

mmol/l

0.24

318

1648

Inflammatory bowel disease treatment related agents

714

3791

1.04

0.53

1.3

1.4

8.82

8.20

mmol/l

3.26

677

3638

Uterine polyps

111

723

0.90

0.51

1.4

8.77

8.07

mmol/l

1.00

103

696

Unspecified maternal hypertension

1.41

0.51

1.7

6.13

7.43

mmol/l

—

Other arthritis (FG)

147

1341

1.10

0.51

1.3

8.75

8.68

mmol/l

0.07

140

1269

malignant neoplasm of male genital organs, including Hilmo

609

0.89

0.50

1.2

9.23

10.08

mmol/l

1.34

566

Atrophic disorders of skin

575

1.15

0.50

1.4

8.51

8.40

mmol/l

0.07

555

Malignant neoplasm of skin

178

1307

0.92

0.49

1.2

9.97

9.23

mmol/l

1.28

158

1226

Brachial plexus disorders

371

1.19

0.49

1.3

1.4

7.49

8.14

mmol/l

0.67

363

Open wound of head

226

2277

0.93

0.49

1.3

9.21

8.96

mmol/l

0.36

216

2145

Other disorders of veins

149

1599

0.92

0.48

1.2

1.3

9.80

8.84

mmol/l

1.68

143

1504

Juvenile arthritis (FINNGEN)

234

0.77

0.48

2.4

1.5

7.03

7.45

mmol/l

0.40

234

Other disorders of ear

473

2909

1.05

0.47

1.3

8.91

8.77

mmol/l

0.29

439

2759

Lichen planus, including avohilmo

625

1.14

0.47

1.3

7.98

9.07

mmol/l

1.63

594

Inflammatory bowel disease

160

1473

1.09

0.47

1.4

8.23

8.34

mmol/l

0.13

152

1402

Abdominal aortic aneurysm (AAA)

209

0.76

0.47

1.3

1.2

11.74

9.77

mmol/l

0.88

191

233

0.77

0.47

1.2

11.99

10.00

mmol/l

0.66

218

Endovascular or surgical operations to intracerebral aneurysms

154

0.71

0.47

1.3

7.42

9.29

mmol/l

1.30

146

Lumbar disc prolapse

332

2321

1.06

0.46

1.3

9.21

8.69

mmol/l

1.27

316

2198

Other fall from one level to another

118

1071

1.10

0.46

1.3

1.4

8.26

8.29

mmol/l

0.03

111

1024

Non-Hodgkin lymphoma, all

103

1.36

0.45

1.0

1.2

10.59

9.69

mmol/l

0.33

Myeloproliferative diseases

210

1.24

0.45

1.4

1.3

9.61

9.62

mmol/l

0.01

198

Organic, including symptomatic, mental disorders

186

1213

1.08

0.44

1.2

10.36

9.48

mmol/l

1.54

170

1135

Other and unspecified nerve root and plexus disorders, also in other diseases

808

1.11

0.44

1.3

8.71

8.82

mmol/l

0.08

760

Hydronephrosis

357

1.18

0.44

1.3

8.46

8.76

mmol/l

0.24

341

Primary open-angle glaucoma, strict

735

0.88

0.44

1.2

9.77

9.50

mmol/l

0.22

691

Abrasion of teeth

169

1566

1.08

0.44

1.2

1.3

8.23

8.61

mmol/l

0.60

156

1476

Malignant neoplasm of ovary

129

0.70

0.43

1.4

7.48

8.30

mmol/l

—

122

Hernia

477

3028

1.05

0.43

1.3

8.86

8.80

mmol/l

0.10

443

2875

Palatinal maxillary operation

1.44

0.43

1.1

1.8

8.59

6.91

mmol/l

—

Other arthrosis

226

1417

1.07

0.43

1.3

1.2

9.69

9.48

mmol/l

0.28

212

1324

Fall on and from stairs and steps

119

1088

1.09

0.42

1.3

9.45

8.52

mmol/l

1.43

110

1043

Congenital mitral valve regurgitation

0.00

0.42

0.0

1.5

—

8.13

—

Rheumatoid arthritis

136

1108

1.09

0.41

1.3

8.85

mmol/l

0.00

129

1045

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.5

—

10.25

—

Brain astrocytoma, including Hilmo

0.00

0.41

0.0

1.6

—

8.69

—

Brain astrocytoma

0.00

0.41

0.0

1.6

—

8.69

—

Glaucoma secondary to eye trauma

0.00

0.41

0.0

1.3

—

8.57

—

Bacterial pneumoniae

177

1446

1.07

0.41

1.3

9.99

8.82

mmol/l

2.46

165

1367

Disorders of conjunctiva

517

3841

1.04

0.41

1.3

1.4

8.39

8.17

mmol/l

0.62

491

3688

Exposure to other specified factors

455

4076

0.96

0.41

1.3

1.4

8.66

8.24

mmol/l

1.22

433

3905

Chronic myringitis

0.00

0.41

0.0

1.1

—

9.09

—

Birth asphyxia

0.00

0.41

0.0

1.6

—

6.41

—

Conjunctivitis

476

3670

1.04

0.40

1.4

8.28

8.09

mmol/l

0.51

452

3530

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

163

1183

0.93

0.40

1.2

9.98

9.25

mmol/l

1.21

146

1108

Non-small cell lung cancer, adenocarcinoma, helper endpoint

149

0.74

0.40

1.3

1.2

7.36

10.27

mmol/l

4.36

138

Hypertrophic scar

223

1.21

0.39

1.3

1.4

8.60

8.01

mmol/l

0.28

218

Other disorders of bone

845

1.10

0.39

1.3

1.4

9.36

8.30

mmol/l

1.08

811

Colorectal adenocarcinoma

590

1.12

0.38

1.2

10.80

9.35

mmol/l

2.00

550

Diabetic retinopathy, excluding more controls

183

1095

0.93

0.38

1.2

1.3

11.76

10.62

mmol/l

2.16

159

993

Primary hyperparathyroidism

289

1.18

0.37

1.2

1.3

11.56

9.08

mmol/l

1.91

275

Atopic dermatitis, strict definition

212

1951

1.06

0.37

1.5

8.28

7.44

mmol/l

2.31

205

1906

Injuries to the shoulder and upper arm

453

3352

1.04

0.37

1.2

1.4

9.11

8.67

mmol/l

1.11

431

3182

Fracture at wrist and hand level

175

1633

1.07

0.37

1.3

1.4

9.61

8.51

mmol/l

1.99

167

1553

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

260

2375

1.06

0.37

1.3

8.63

8.67

mmol/l

0.06

250

2253

Disorders of choroid and retina

360

2406

1.05

0.36

1.2

1.3

10.26

9.04

mmol/l

5.15

328

2263

Non-small cell lung cancer, adenocarcinoma

146

0.75

0.36

1.3

1.2

7.36

10.03

mmol/l

3.92

134

Fall on same level

690

3798

0.97

0.36

1.3

1.4

9.17

8.09

mmol/l

7.32

652

3645

Whooping cough

1.44

0.36

2.0

1.6

6.07

7.25

mmol/l

—

Acne vulgaris

582

1.12

0.35

1.5

1.6

7.70

7.07

mmol/l

0.80

577

Oesophageal obstruction

0.64

0.35

1.0

1.2

10.70

9.47

mmol/l

—

Benign lipomatous neoplasm

115

1062

1.08

0.35

1.1

1.3

8.24

9.10

mmol/l

1.70

109

993

Serous carcinoma of ovary, including Hilmo

0.62

0.35

1.4

1.3

7.50

8.45

mmol/l

—

Gonarthrosis, primary, with knee surgery

215

1579

1.06

0.35

1.2

8.72

9.78

mmol/l

3.53

201

1460

Postmenopausal bleeding

404

1.10

0.34

1.2

9.16

9.29

mmol/l

0.11

382

Presbyopia

227

1.19

0.34

1.1

1.3

9.13

9.39

mmol/l

0.13

214

Thyroiditis

276

0.83

0.34

1.6

1.4

7.74

8.31

mmol/l

0.27

265

Skin changes due to chronic exposure to nonionizing radiation

110

1077

0.92

0.34

1.1

1.2

9.52

9.55

mmol/l

0.02

1007

Disorders of vitreous body

200

1795

1.06

0.34

1.3

1.2

9.13

9.32

mmol/l

0.25

192

1672

Hypertrophic disorders of skin

246

1.18

0.34

1.3

1.5

8.66

7.93

mmol/l

0.40

240

Postviral fatigue syndrome

1.34

0.34

2.0

1.6

6.30

7.59

mmol/l

—

Actinic keratosis

105

1034

0.92

0.33

1.1

1.2

9.68

9.59

mmol/l

0.08

969

Other degenerative diseases of the nervous system

107

720

1.08

0.33

1.2

1.3

9.69

8.67

mmol/l

1.41

682

Alzheimer disease

617

0.91

0.31

1.1

1.2

9.38

9.86

mmol/l

0.50

572

Mental retardation, wide definition

141

0.77

0.31

1.2

1.4

9.31

8.56

mmol/l

0.14

136

Systemic atrophies primarily affecting the central nervous system

0.72

0.31

1.1

1.2

9.53

9.28

mmol/l

—

Oral corticosteroids

632

3594

1.03

0.30

1.3

1.4

9.04

8.27

mmol/l

4.14

598

3441

Injuries to the elbow and forearm

385

3423

0.96

0.30

1.3

1.4

8.72

8.27

mmol/l

1.13

368

3274

Dementia, including avohilmo

152

974

1.06

0.30

1.1

1.2

10.11

9.59

mmol/l

0.65

141

910

Other benign neoplasms of uterus

102

1.28

0.30

1.4

1.3

7.87

8.82

mmol/l

0.28

Postpartum haemorrhage due to retained placenta

119

1273

0.93

0.30

1.5

1.6

6.12

6.81

mmol/l

4.30

119

1252

Malignant neoplasm of thyroid gland, including Hilmo

249

0.84

0.29

1.3

1.4

8.34

8.46

mmol/l

0.05

240

Tinnitus

901

1.08

0.28

1.3

8.89

8.74

mmol/l

0.10

850

Spondylopathies (FG)

574

1.10

0.28

1.5

1.4

7.44

8.41

mmol/l

1.54

555

Cleft palate

1.30

0.28

1.5

1.6

8.61

7.38

mmol/l

—

Subacute thyroiditis

129

0.77

0.28

1.8

1.5

8.53

8.50

mmol/l

—

123

Infections with a predominantly sexual mode of transmission

207

1967

1.05

0.28

1.4

1.5

8.57

7.47

mmol/l

2.90

198

1924

Achilles tendinitis

355

1.13

0.28

1.1

1.3

8.19

9.26

mmol/l

1.12

332

Deep bite

413

0.89

0.28

1.5

1.4

7.55

7.91

mmol/l

0.29

403

Injury of eye and orbit

594

1.10

0.27

1.4

8.86

8.62

mmol/l

0.15

569

Excessive attrition of teeth

372

3552

1.04

0.27

1.4

8.23

8.14

mmol/l

0.18

364

3396

Abnormal findings on diagnostic imaging of lung

180

1618

1.05

0.27

1.2

10.66

9.49

mmol/l

2.58

167

1498

Chronic sinusitis

214

2039

1.05

0.27

1.3

1.4

8.62

8.42

mmol/l

0.30

198

1939

Injury of other and unspecified intrathoracic organs

168

1.19

0.27

1.2

1.3

10.56

9.15

mmol/l

0.45

162

Vasculitis limited to skin, not elsewhere classified

1.21

0.26

1.1

1.3

10.99

9.01

mmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

191

1954

0.95

0.26

1.4

1.5

6.91

7.28

mmol/l

1.16

185

1906

therapeutic use

0.67

0.26

1.4

1.2

11.50

9.04

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

150

1422

1.06

0.25

1.4

1.5

7.65

7.36

mmol/l

0.45

144

1394

Disorders of vitreous body and globe

203

1833

1.05

0.25

1.3

1.2

9.12

9.33

mmol/l

0.31

195

1709

Fall involving bed

1.22

0.25

1.2

1.3

11.14

9.08

mmol/l

—

Other and unspecified iridocyclitis

159

0.82

0.24

1.5

1.4

8.52

8.81

mmol/l

0.11

154

Artificial joint re-operation

159

0.82

0.24

1.3

1.2

9.15

9.58

mmol/l

0.14

150

Polycythaemia vera

1.19

0.24

1.2

1.1

8.59

9.37

mmol/l

—

Status epilepticus

0.70

0.24

1.5

1.4

6.98

8.63

mmol/l

—

Left ventricular outflow tract obstruction, narrow definition

152

1.19

0.23

1.5

1.4

8.23

9.09

mmol/l

0.51

146

Abnormal spermatozoa

370

0.89

0.23

1.1

1.2

8.38

10.05

mmol/l

2.03

336

Primary open-angle glaucoma

865

0.93

0.23

1.2

10.01

9.49

mmol/l

0.63

811

Contact with machinery

370

1.11

0.23

1.1

1.3

10.54

9.58

mmol/l

0.43

348

Precocious puberty

1.29

0.23

1.0

1.8

6.46

6.93

mmol/l

—

Carcinoma in situ of skin of lower limb, including hip

1.28

0.23

1.2

1.1

8.36

10.76

mmol/l

—

External causes of morbidity and mortality

430

2092

1.03

0.23

1.4

8.53

7.86

mmol/l

2.56

414

2023

Colorectal cancer

725

1.07

0.22

1.2

10.45

9.28

mmol/l

1.75

680

Cleft hard palate NOS

1.26

0.22

1.8

1.7

10.00

7.20

mmol/l

—

Other/unspecified synovitis and tenosynovitis

400

1.10

0.22

1.3

1.4

9.27

8.37

mmol/l

0.50

383

Special screening examination for other diseases and disorders

467

1.09

0.22

1.3

1.4

9.43

7.78

mmol/l

1.97

453

Residual foreign body in soft tissue

172

1.16

0.22

1.6

1.4

7.09

8.53

mmol/l

1.36

167

Degenerative diseases of the nervous system

734

0.94

0.22

1.1

1.2

9.78

9.80

mmol/l

0.02

684

Any dementia

120

785

1.06

0.22

1.1

1.2

9.65

9.66

mmol/l

0.01

112

729

Fusion of the labia

0.00

0.21

0.0

2.0

—

6.69

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.21

0.0

1.7

—

8.34

—

Fetal death of unspecified cause

0.00

0.21

0.0

1.7

—

7.15

—

Other and unspecified thalassaemias

0.00

0.21

0.0

1.6

—

9.03

—

Transient global amnesia

210

1.14

0.21

1.2

7.65

9.67

mmol/l

2.27

195

Diphtheria, including avohilmo

0.00

0.21

0.0

1.5

—

7.51

—

Labyrinthine fistula

0.00

0.21

0.0

1.3

—

10.12

—

Absence of one kidney, including avohilmo

0.00

0.21

0.0

1.6

—

9.37

—

Generalized pustular psoriasis

0.00

0.21

0.0

1.1

—

9.89

—

Carcinoma in situ of prostate

0.00

0.21

0.0

1.0

—

11.99

—

Fusion of the labia, including avohilmo

0.00

0.21

0.0

1.9

—

6.80

—

Congenital absence of the uterus

0.00

0.21

0.0

1.7

—

8.18

—

In situ neoplasms

191

1833

1.04

0.21

1.3

1.4

8.53

8.32

mmol/l

0.29

181

1749

Multiple superficial injuries of ankle and foot

0.00

0.21

0.0

1.4

—

8.08

—

Artificial joint operation, meniscal resection

398

2472

1.03

0.21

1.2

1.3

9.03

9.34

mmol/l

0.70

377

2311

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.5

—

8.05

—

Osteosarcoma

0.00

0.21

0.0

1.4

—

8.53

—

Essential (haemorrhagic) thrombocythaemia

1.23

0.21

1.4

1.2

10.94

9.08

mmol/l

0.67

Fracture of forearm

267

2480

0.97

0.21

1.3

1.4

8.97

8.38

mmol/l

1.20

252

2370

Acute necrotizing ulcerative gingivitis, including avohilmo

0.00

0.21

0.0

1.6

—

6.65

—

Infections with a predominantly sexual mode of transmission, including avohilmo

293

2595

1.03

0.20

1.4

1.5

8.30

7.42

mmol/l

2.95

280

2537

Other disorders of pigmentation

134

0.82

0.20

1.5

1.4

8.55

8.70

mmol/l

0.06

129

Congenital vesicoureteral reflux

1.26

0.20

1.2

1.6

5.48

6.90

mmol/l

—

Frostbite with tissue necrosis

0.00

0.20

0.0

1.4

—

9.54

—

Testicular dysfunction, other/unspecified

0.00

0.20

0.0

1.1

—

13.06

—

Sequelae of injuries, of poisoning and of other consequences of external causes

103

975

1.06

0.20

1.4

1.3

9.58

8.79

mmol/l

0.91

923

Malignant neoplasm, without specification of site, including Hilmo

1.21

0.19

1.2

10.24

9.20

mmol/l

0.30

Acute laryngitis and tracheitis

607

1.07

0.19

1.5

7.15

7.63

mmol/l

0.59

592

Sensorineural hearing loss

321

2077

1.03

0.19

1.2

9.20

9.31

mmol/l

0.19

294

1948

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

137

1.17

0.18

1.3

1.4

7.93

9.00

mmol/l

0.77

132

Lichen ruber planus, wide definition including periferal and oral lichen planus

794

1.06

0.18

1.2

1.3

8.01

9.02

mmol/l

1.74

750

Other specified/unspecified spondylopathies

1.19

0.18

1.1

1.2

14.76

9.93

mmol/l

—

Erectile dysfunction

204

1.13

0.18

1.3

1.2

9.68

10.40

mmol/l

0.41

190

Effects of foreign body entering through natural orifice

1031

0.95

0.18

1.3

8.47

8.87

mmol/l

0.45

973

Zoster [herpes zoster]

619

1.07

0.18

1.3

10.43

8.91

mmol/l

1.49

589

Viral infections characterized by skin and mucous membrane lesions

211

2039

1.03

0.17

1.3

1.4

9.10

8.45

mmol/l

1.24

202

1936

Malignant neoplasm, without specification of site

1.15

0.17

1.3

1.2

9.89

9.48

mmol/l

—

L04AX Other immunosuppressants

263

2705

0.97

0.17

1.3

1.4

9.02

8.52

mmol/l

0.98

250

2567

Any dementia, excluding more controls

112

734

1.05

0.16

1.1

1.2

9.73

9.51

mmol/l

0.20

104

684

Mandibular retrognathia

291

1.10

0.16

1.5

7.28

7.91

mmol/l

0.52

286

Injury, poisoning and certain other consequences of external causes

345

1686

1.03

0.16

1.4

8.44

7.79

mmol/l

2.13

333

1630

Striking against or struck by other objects

177

1709

1.03

0.15

1.4

8.22

8.38

mmol/l

0.20

167

1634

Social phobias

524

0.93

0.15

1.3

1.6

9.35

7.17

mmol/l

2.01

515

Phobic anxiety disorders

866

1.05

0.15

1.3

1.5

9.09

7.25

mmol/l

2.92

850

Temporomandibular joint disorders, including avohilmo

293

2906

0.98

0.15

1.5

7.34

7.62

mmol/l

0.80

287

2821

Other secondary coxarthrosis

1.08

0.14

1.4

1.2

9.34

9.17

mmol/l

—

Bacterial pneumonia, not elsewhere classified

158

1343

1.03

0.13

1.3

10.02

8.80

mmol/l

2.42

149

1269

Dementia

138

911

1.04

0.13

1.1

1.2

10.05

9.58

mmol/l

0.54

128

849

Medicines for HER+ breast cancer

123

1187

0.96

0.13

1.3

8.44

8.76

mmol/l

0.45

117

1128

Chronic rhinitis, nasopharyngitis and pharyngitis

159

1541

1.03

0.13

1.3

1.4

9.07

8.36

mmol/l

1.27

145

1466

Malignant neoplasm of skin, including Hilmo

201

1383

0.97

0.13

1.2

9.87

9.22

mmol/l

1.15

178

1296

Meningitis

159

0.88

0.13

1.4

1.5

8.85

8.73

mmol/l

0.03

154

Other inflammation of eyelid, including avohilmo

264

2699

0.98

0.12

1.4

8.30

7.86

mmol/l

1.05

253

2594

Other juvenile arthritis

200

0.90

0.12

2.4

1.5

7.03

7.27

mmol/l

0.20

200

COPD, hospital admissions 1, only main diagnosis

110

913

1.04

0.11

1.2

9.88

9.44

mmol/l

0.40

854

Ovarian cyst

242

1353

1.02

0.11

1.5

7.48

7.23

mmol/l

0.50

232

1324

Other endocrine disorders

211

1.09

0.11

1.5

6.94

7.78

mmol/l

0.55

206

Hypermetropia

269

1.08

0.11

1.4

1.5

7.59

8.07

mmol/l

0.45

261

Second line medication for Crohn's disease

278

2829

0.98

0.10

1.3

1.4

8.98

8.48

mmol/l

1.02

265

2687

Clear cell adenocarcinoma of kidney

125

0.88

0.10

1.3

1.2

11.65

9.57

mmol/l

0.65

112

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

316

3075

0.98

0.10

1.4

8.25

7.92

mmol/l

0.84

299

2968

Use of fingolimod

1.11

0.10

1.2

1.7

5.68

7.76

mmol/l

—

Colorectal cancer, including Hilmo

811

1.03

0.09

1.2

10.60

9.28

mmol/l

2.02

761

Injuries to the head

677

3971

1.01

0.09

1.4

8.90

8.20

mmol/l

3.65

642

3808

Other specified/unspecified arthritis

120

1169

1.03

0.09

1.3

8.84

8.58

mmol/l

0.27

114

1106

Assault by blunt object

1.09

0.09

1.3

1.4

6.18

8.62

mmol/l

—

Enthesopathies of lower limb, excluding foot

922

1.03

0.08

1.2

1.3

8.17

8.83

mmol/l

0.91

862

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.07

0.08

1.5

1.7

5.20

7.44

mmol/l

—

Allergic conjunctivitis

331

3227

0.99

0.08

1.4

8.20

7.92

mmol/l

0.70

314

3117

Use of levodopa decarbox-comt-inhibitor

0.78

0.08

1.4

1.2

9.98

9.96

mmol/l

—

Otitis media, unspecified

568

1.04

0.08

1.5

7.87

7.51

mmol/l

0.41

560

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

536

4125

1.01

0.08

1.4

8.57

8.29

mmol/l

0.81

512

3950

Malignant neoplasm of endocrine gland, including Hilmo

277

0.94

0.08

1.3

1.4

8.02

8.43

mmol/l

0.21

268

Biomechanical lesions, not elsewhere classified

156

1.09

0.08

1.2

1.4

8.73

8.90

mmol/l

0.08

150

Other benign neoplasm of uterus: Other parts/unspecified

1.06

0.08

1.0

1.2

8.54

9.13

mmol/l

—

Benign intracranial hypertension

0.84

0.07

1.5

1.6

6.88

7.37

mmol/l

—

Use of ropinirole

0.81

0.07

1.3

1.2

8.75

9.46

mmol/l

—

Adhesive capsulitis of shoulder

540

0.96

0.07

1.1

1.3

9.21

9.05

mmol/l

0.10

502

Hereditary corneal dystrophies

0.82

0.07

1.1

1.3

10.30

9.64

mmol/l

—

Normal-pressure hydrocephalus

0.82

0.07

1.0

1.2

8.94

10.23

mmol/l

—

Fenamates

505

0.97

0.07

1.3

1.4

7.60

7.89

mmol/l

0.39

490

Other and unspecified abdominal hernia

104

0.86

0.06

1.4

1.3

9.21

9.09

mmol/l

—

Complications of other internal prosthetic devices, implants and grafts

111

0.90

0.06

1.4

10.05

8.70

mmol/l

—

105

Papillary adenocarcinoma of thyroid gland

162

0.93

0.06

1.3

1.5

7.82

8.54

mmol/l

0.32

155

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

785

0.98

0.06

1.2

10.30

9.31

mmol/l

0.97

736

Congenital malformations of ovaries, fallopian tubes and broad ligaments

296

1.05

0.05

1.5

6.52

7.50

mmol/l

1.72

291

Erosion of teeth , including avohilmo

154

1516

1.02

0.05

1.4

7.94

7.93

mmol/l

0.01

149

1465

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

324

0.96

0.05

1.3

1.4

9.38

8.97

mmol/l

0.20

309

Juvenile rheumatoid arthirtis

100

1.10

0.05

2.5

1.5

6.60

7.99

mmol/l

1.21

100

Benign neoplasm of ovary

566

0.97

0.05

1.3

9.19

8.40

mmol/l

0.57

544

Malignant neoplasm of thyroid gland

222

0.95

0.05

1.3

1.4

8.34

8.45

mmol/l

0.04

213

Open wound of wrist and hand

245

2341

1.01

0.05

1.3

1.4

8.97

8.46

mmol/l

0.92

233

2233

Presence of other functional implants

221

1495

1.01

0.04

1.3

1.2

9.32

9.41

mmol/l

0.11

202

1396

Peritonsillar abscess

111

1129

0.98

0.04

1.4

8.27

7.97

mmol/l

0.37

104

1084

Exposure to other specified electric current

101

1.09

0.04

2.0

1.5

7.87

8.56

mmol/l

0.29

101

127

1158

0.99

0.04

1.2

9.61

9.53

mmol/l

0.07

115

1083

Finngen Rheumatological endpoints

585

3337

0.99

0.04

1.3

1.4

8.35

8.19

mmol/l

0.40

555

3205

L01XX Other antineoplastic agents

131

1.07

0.03

1.1

1.2

9.48

10.14

mmol/l

0.27

123

Systemic lupus erythematosus

118

0.93

0.02

1.3

1.5

11.95

8.53

mmol/l

0.47

113

L01XE Protein kinase inhibitors

118

0.93

0.02

1.3

10.82

9.82

mmol/l

0.21

110

Malignant neoplasm of endocrine gland

241

1.04

0.02

1.3

1.4

8.00

8.56

mmol/l

0.28

232

Endometriosis of rectovaginal septum and vagina

301

1.03

0.02

1.4

8.41

7.87

mmol/l

0.37

292

Coxarthrosis, primary, with hip surgery

154

1416

1.01

0.02

1.2

9.48

9.64

mmol/l

0.16

139

1316

Other diseases of pleura

155

1355

0.99

0.01

1.2

9.72

9.43

mmol/l

0.34

140

1269

Hydrocephalus

173

1.04

0.01

1.0

1.3

8.86

9.60

mmol/l

0.34

161

Rheumatoid arthritis, including avohilmo

147

1461

1.01

0.01

1.3

8.72

8.75

mmol/l

0.03

140

1378

Degeneration of macula and posterior pole

154

1181

1.01

0.01

1.2

10.18

9.41

mmol/l

1.32

140

1108

Endometriosis

220

1284

1.00

0.01

1.4

1.5

7.43

7.29

mmol/l

0.26

212

1255

Oxicams

537

0.99

0.00

1.3

1.4

8.14

8.50

mmol/l

0.45

515

Asthma and opportunity respiratory infection

105

0.95

0.00

1.1

1.3

10.96

9.70

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

360

3248

1.00

0.00

1.3

1.4

8.37

8.17

mmol/l

0.38

346

3110

Lesion of sciatic nerve

1.04

0.00

1.1

1.2

12.02

10.22

mmol/l

—

Retinal detachments and breaks

123

1229

1.00

0.00

1.3

1.2

9.60

9.30

mmol/l

0.33

114

1156

Oral lichen planus, including avohilmo , including avohilmo

202

0.99

0.00

1.2

1.3

9.40

8.97

mmol/l

0.15

192

SLE (Finngen)

111

0.99

0.00

1.3

1.5

11.95

7.86

mmol/l

0.60

106

Deep endometriosis

397

1.01

0.00

1.4

8.33

7.75

mmol/l

0.49

383

Calcium deposit in bursa

0.00

0.0

1.0

—

10.42

—

Macrocephaly

0.00

0.0

1.0

—

10.44

—

Rickettsioses

0.00

0.0

1.4

—

8.72

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.4

—

8.40

—

Postinflammatory hyperpigmentation

0.00

0.0

1.7

—

6.75

—

Pectus carinatum, including avohilmo

0.00

0.0

1.5

—

10.38

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

0.0

1.5

—

8.67

—

Cardiovascular disorders originating in the perinatal period

0.00

0.0

1.9

—

6.60

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.97

0.00

1.0

1.3

9.85

8.48

mmol/l

—

Albinism

0.00

0.0

1.7

—

5.92

—

Contact with other specified venomous plants

0.00

0.0

1.8

—

6.44

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.2

—

7.26

—

Leishmaniasis, including avohilmo

0.00

0.0

1.4

—

8.04

—

Other haemoglobinopathies

0.00

0.0

1.7

—

7.58

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.0

1.2

—

10.23

—

Pectus carinatum

0.00

0.0

1.5

—

10.38

—

Erythema annulare centrifugum

0.00

0.0

1.0

—

10.28

—

Abnormal pulmonary venous return

0.00

0.0

1.5

—

8.86

—

Benign neoplasm: Scrotum

0.00

0.0

1.4

—

10.81

—

Prolapse and hernia of ovary and fallopian tube

0.99

0.00

1.0

1.2

10.62

10.16

mmol/l

—

Failed attempted abortion

0.92

-0.00

1.9

1.5

7.96

7.06

mmol/l

—

Lichen striatus

0.00

-0.00

0.0

1.0

—

10.46

—

Dengue fever [classical dengue], including avohilmo

0.00

-0.00

0.0

1.7

—

6.51

—

Other protozoal diseases, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.4

—

8.66

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

1.4

—

11.26

—

Dengue, including avohilmo

0.00

-0.00

0.0

1.2

—

11.14

—

Diphtheria

0.00

-0.00

0.0

1.6

—

7.80

—

Erythrasma

0.00

-0.00

0.0

1.5

—

7.47

—

Aortic arch syndrome [Takayasu]

0.00

-0.00

0.0

1.6

—

11.59

—

Other specific arthropathies

0.00

-0.00

0.0

1.0

—

9.07

—

Myositis ossificans

0.00

-0.00

0.0

1.1

—

10.24

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

1.8

—

6.04

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.7

—

5.75

—

Oher contracture of tendon (sheath)

0.00

-0.00

0.0

1.8

—

7.55

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.4

—

8.27

—

Cryoglobulinemia

0.00

-0.00

0.0

1.4

—

6.88

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.6

—

6.44

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

9.93

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.1

—

8.96

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.8

—

5.52

—

Other rickettsioses, including avohilmo

0.00

-0.00

0.0

1.8

—

7.32

—

Hypoparathyroidism

0.91

-0.00

1.2

1.4

7.76

8.85

mmol/l

—

Pityriasis rubra pilaris

0.00

-0.00

0.0

1.4

—

6.64

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

8.38

—

Profound mental retardation

0.00

-0.00

0.0

1.8

—

6.38

—

Chronic bullous disease of childhood

0.00

-0.00

0.0

1.7

—

6.79

—

Erythema in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

7.50

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.8

—

6.95

—

Injury of heart

0.00

-0.00

0.0

1.6

—

8.40

—

Abuse of non-dependence-producing substances

0.00

-0.00

0.0

1.8

—

9.58

—

Crushing injury of lower leg

0.00

-0.00

0.0

1.4

—

8.86

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.0

—

10.69

—

Specific developmental disorder of motor function

0.87

-0.00

1.2

1.8

8.18

7.19

mmol/l

—

Disorders of sexual preference

0.00

-0.00

0.0

1.3

—

8.48

—

Deficiency of other/unspecified vitamins

0.00

-0.00

0.0

1.2

—

9.61

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.2

—

10.96

—

Motor disorders, excluding more controls

1.00

-0.00

1.2

1.8

8.18

6.37

mmol/l

—

Other combined immunodeficiencies

0.00

-0.00

0.0

1.8

—

8.12

—

Severe mental retardation

0.00

-0.00

0.0

1.4

—

7.02

—

Disorders of vagus nerve

0.00

-0.00

0.0

1.2

—

5.44

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.3

—

12.26

—

Assault by other and unspecified firearm discharge

0.00

-0.00

0.0

1.8

—

7.80

—

Other congenital malformations of spinal cord

0.00

-0.00

0.0

1.4

—

11.16

—

Polyp of middle ear

0.00

-0.00

0.0

1.5

—

11.92

—

Discharge of firework

0.00

-0.00

0.0

1.5

—

8.55

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.2

—

9.85

—

Polydactyly

0.00

-0.00

0.0

1.6

—

7.02

—

Other congenital malformations of respiratory system

0.00

-0.00

0.0

1.5

—

8.50

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.3

—

10.23

—

Complicated migraine, drug-induced

0.00

-0.00

0.0

1.6

—

7.80

—

Exposure to uncontrolled fire, not in building or structure

0.00

-0.00

0.0

1.9

—

7.17

—

Nontoxic diffuse goitre

0.96

-0.00

1.4

1.3

7.45

9.17

mmol/l

—

Congenital malposition of the kidney

0.00

-0.00

0.0

2.2

—

7.23

—

Absence of one kidney

0.00

-0.00

0.0

1.9

—

9.31

—

Microcephaly

0.00

-0.00

0.0

1.4

—

7.60

—

Ankylosis of teeth

0.00

-0.00

0.0

1.0

—

9.20

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.2

—

10.48

—

Benign neoplasm: Thymus

0.00

-0.00

0.0

1.8

—

9.80

—

Congenital absence, atresia and stenosis of large intestine

0.00

-0.00

0.0

2.1

—

6.91

—

Aortic stenosis

0.00

-0.00

0.0

1.4

—

6.14

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.2

—

7.16

—

Legal intervention

0.00

-0.00

0.0

1.2

—

10.88

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.0

—

10.45

—

Beta thalassaemia

0.00

-0.00

0.0

1.4

—

11.36

—

Failure of sterile precautions during surgical operation

0.00

-0.00

0.0

1.3

—

8.27

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.6

—

8.24

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

1.4

—

6.40

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.6

—

8.80

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

11.32

—

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.6

—

7.19

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.6

—

8.22

—

Pelvic region

0.00

-0.00

0.0

1.4

—

6.10

—

Victim of lightning

0.00

-0.00

0.0

1.2

—

9.25

—

Encephalocele

0.00

-0.00

0.0

1.7

—

5.73

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.3

—

6.57

—

Hirsprung

0.00

-0.00

0.0

1.7

—

5.82

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.4

—

11.40

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.4

—

8.80

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.2

—

9.78

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.9

—

8.44

—

Fibrothorax

0.00

-0.00

0.0

1.0

—

10.52

—

Ovarian dysfunction: estrogen excess

0.00

-0.00

0.0

1.6

—

6.41

—

Rare circulating lymphoid malignancy

0.00

-0.00

0.0

1.0

—

11.32

—

Chromophobe cell carcinoma of kidney

0.00

-0.00

0.0

1.3

—

11.42

—

Congenital edentulism

0.00

-0.00

0.0

1.3

—

5.80

—

Alpha thalassaemia

0.00

-0.00

0.0

1.3

—

6.99

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

2.0

—

9.19

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

2.0

—

5.80

—

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.4

—

5.86

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS